{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:45:01Z","timestamp":1794033901387,"version":"4.8.0"},"reference-count":325,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA-DA000635"],"award-info":[{"award-number":["ZIA-DA000635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA-DA000635"],"award-info":[{"award-number":["ZIA-DA000635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R37DA020686"],"award-info":[{"award-number":["R37DA020686"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA024103"],"award-info":[{"award-number":["R01AA024103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Investigating similarities and differences between alcohol use disorder (AUD) and obesity is important because both AUD and obesity are public health concerns and share neurobiological and periphery-brain mechanisms. Furthermore, AUD and obesity often present with similar medical consequences related to organ damage, including liver and cardiovascular diseases. There is also growing evidence of changes in alcohol drinking in people who undergo bariatric surgery for obesity. In this non-systematic critical review, we identified relevant articles through PubMed searches, previous knowledge, and recursive reference searching. A librarian also used PubMed and Google Scholar for additional relevant articles, using terms such as alcohol, metabolic disorders, obesity, glucagon-like peptide-1 (GLP-1), bariatric surgery, and gut-brain axis. We provide an overview of the neurobiological, pathophysiological, neuroimaging, and clinical features related to the overlap and crosstalk between AUD and obesity. We also provide a summary of the currently approved medications for obesity and those for AUD and note the potential for some of these medications to work for both disorders. Specific to the latter point, we place emphasis on GLP-1\u00a0therapies, given their recent approval for weight loss and the growing evidence suggesting their potential efficacy for AUD and other addictions. We further review studies of the relationship between bariatric surgery and AUD and discuss potential mechanisms and future directions. In summary, studying the overlap between obesity and AUD may shed light on the mechanisms underlying the development and maintenance of both diseases. This knowledge, in turn, may help identify new therapeutic targets for AUD, and possibly comorbid obesity and\/or other metabolic disorders.<\/jats:p>","DOI":"10.1038\/s41380-025-03259-8","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:28:14Z","timestamp":1758994094000},"page":"5938-5952","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Crosstalk between alcohol use disorder and obesity: two sides of the same coin?"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-8754","authenticated-orcid":false,"given":"Lorenzo","family":"Leggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-4212","authenticated-orcid":false,"given":"Mehdi","family":"Farokhnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2426-3641","authenticated-orcid":false,"given":"Paul J.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Yanina","family":"Pepino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-9003","authenticated-orcid":false,"given":"W. Kyle","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"3259_CR1","unstructured":"Fryar C, Carroll M, Afful J. Prevalence of overweight, obesity, and extreme obesity among adults aged 20 and over: United States, 1960\u20131962 through 2017\u20132018. 2021. 2021\/02\/05\/T09:41:45Z. Accessed 2024\/10\/18\/23:58:26. https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity-adult-17-18\/obesity-adult.htm."},{"key":"3259_CR2","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey of Drug Use and Health (NSDUH) Releases. 2022."},{"key":"3259_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2023.100525","volume":"23","author":"SA Raza","year":"2023","unstructured":"Raza SA, Sokale IO, Thrift AP. Burden of high-risk phenotype of heavy alcohol consumption among obese U.S. population: results from National Health and Nutrition Examination Survey, 1999\u20132020. Lancet Reg Health Am. 2023;23:100525. https:\/\/doi.org\/10.1016\/j.lana.2023.100525.","journal-title":"Lancet Reg Health Am"},{"key":"3259_CR4","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.2105\/AJPH.2016.303326","volume":"106","author":"A Hruby","year":"2016","unstructured":"Hruby A, Manson JE, Qi L, Malik VS, Rimm EB, Sun Q, et al. Determinants and consequences of obesity. Am J Public Health. 2016;106:1656\u201362. https:\/\/doi.org\/10.2105\/AJPH.2016.303326.","journal-title":"Am J Public Health"},{"key":"3259_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1176\/appi.ajp.20230488","volume":"180","author":"HR Kranzler","year":"2023","unstructured":"Kranzler HR. Overview of alcohol use disorder. Am J Psychiatry. 2023;180:565\u201372. https:\/\/doi.org\/10.1176\/appi.ajp.20230488.","journal-title":"Am J Psychiatry"},{"key":"3259_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/er.2017-00111","volume":"38","author":"MW Schwartz","year":"2017","unstructured":"Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, et al. Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev. 2017;38:267\u201396. https:\/\/doi.org\/10.1210\/er.2017-00111.","journal-title":"Endocr Rev"},{"key":"3259_CR7","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). 5th ed. Washington, DC: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"3259_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/alcalc\/35.1.10","volume":"35","author":"K Mann","year":"2000","unstructured":"Mann K. One hundred years of alcoholism: the twentieth century. Alcohol Alcohol. 2000;35:10\u201315. https:\/\/doi.org\/10.1093\/alcalc\/35.1.10.","journal-title":"Alcohol Alcohol"},{"key":"3259_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.appet.2013.04.001","volume":"68","author":"JL Lusk","year":"2013","unstructured":"Lusk JL, Ellison B. Who is to blame for the rise in obesity? Appetite. 2013;68:14\u201320. https:\/\/doi.org\/10.1016\/j.appet.2013.04.001.","journal-title":"Appetite"},{"key":"3259_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s13679-018-0304-0","volume":"7","author":"FC Stanford","year":"2018","unstructured":"Stanford FC, Tauqeer Z, Kyle TK. Media and its influence on obesity. Curr Obes Rep. 2018;7:186\u201392. https:\/\/doi.org\/10.1007\/s13679-018-0304-0.","journal-title":"Curr Obes Rep"},{"key":"3259_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/SAR.S183256","volume":"9","author":"RA Hammarlund","year":"2018","unstructured":"Hammarlund RA, Crapanzano KA, Luce L, Mulligan LA, Ward KM. Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders. SAR. 2018;9:115\u201336. https:\/\/doi.org\/10.2147\/SAR.S183256.","journal-title":"SAR"},{"key":"3259_CR12","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/aje\/kwq304","volume":"172","author":"KM Keyes","year":"2010","unstructured":"Keyes KM, Hatzenbuehler ML, McLaughlin KA, Link B, Olfson M, Grant BF, et al. Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol. 2010;172:1364\u201372. https:\/\/doi.org\/10.1093\/aje\/kwq304.","journal-title":"Am J Epidemiol"},{"key":"3259_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s13679-023-00495-3","volume":"12","author":"S Westbury","year":"2023","unstructured":"Westbury S, Oyebode O, Van Rens T, Barber TM. Obesity stigma: causes, consequences, and potential solutions. Curr Obes Rep. 2023;12:10\u201323. https:\/\/doi.org\/10.1007\/s13679-023-00495-3.","journal-title":"Curr Obes Rep"},{"key":"3259_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23:120\u201333. https:\/\/doi.org\/10.1038\/s41576-021-00414-z.","journal-title":"Nat Rev Genet"},{"key":"3259_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1017\/S0033291714002165","volume":"45","author":"B Verhulst","year":"2015","unstructured":"Verhulst B, Neale MC, Kendler KS. The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies. Psychol Med. 2015;45:1061\u201372. https:\/\/doi.org\/10.1017\/S0033291714002165.","journal-title":"Psychol Med"},{"key":"3259_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172885","volume":"134","author":"H Zhou","year":"2024","unstructured":"Zhou H, Gelernter J. Human genetics and epigenetics of alcohol use disorder. J Clin Invest. 2024;134:e172885. https:\/\/doi.org\/10.1172\/JCI172885.","journal-title":"J Clin Invest"},{"key":"3259_CR17","first-page":"67","volume":"2010","author":"RA Grucza","year":"2010","unstructured":"Grucza RA, Krueger RF, Racette SB, Norberg KE, Hipp PR, Bierut LJ. The emerging link between alcoholism risk and obesity in the United States. Arch Gen Psychiatry. 2010;2010:67.","journal-title":"Arch Gen Psychiatry"},{"key":"3259_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.copsyc.2018.07.012","volume":"27","author":"JD Deak","year":"2019","unstructured":"Deak JD, Miller AP, Gizer IR. Genetics of alcohol use disorder: a review. Curr Opin Psychol. 2019;27:56\u201361. https:\/\/doi.org\/10.1016\/j.copsyc.2018.07.012.","journal-title":"Curr Opin Psychol"},{"key":"3259_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41586-022-05477-4","volume":"612","author":"GRB Saunders","year":"2022","unstructured":"Saunders GRB, Wang X, Chen F, Jang SK, Liu M, Wang C, et al. Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature. 2022;612:720\u20134. https:\/\/doi.org\/10.1038\/s41586-022-05477-4.","journal-title":"Nature"},{"key":"3259_CR20","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1038\/s41591-023-02653-5","volume":"29","author":"H Zhou","year":"2023","unstructured":"Zhou H, Kember RL, Deak JD, Xu H, Toikumo S, Yuan K, et al. Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. Nat Med. 2023;29:3184\u201392. https:\/\/doi.org\/10.1038\/s41591-023-02653-5.","journal-title":"Nat Med"},{"key":"3259_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41562-025-02148-y","volume":"9","author":"SG Malone","year":"2025","unstructured":"Malone SG, Davis CN, Piserchia Z, Setzer MR, Toikumo S, Zhou H, et al. Alcohol use disorder and body mass index show genetic pleiotropy and shared neural associations. Nat Hum Behav. 2025;9:1056\u201366. https:\/\/doi.org\/10.1038\/s41562-025-02148-y.","journal-title":"Nat Hum Behav"},{"key":"3259_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.amepre.2014.07.005","volume":"47","author":"B Ghosh-Dastidar","year":"2014","unstructured":"Ghosh-Dastidar B, Cohen D, Hunter G, Zenk SN, Huang C, Beckman R, et al. Distance to store, food prices, and obesity in urban food deserts. Am J Prev Med. 2014;47:587\u201395. https:\/\/doi.org\/10.1016\/j.amepre.2014.07.005.","journal-title":"Am J Prev Med"},{"key":"3259_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/epirev\/mxm009","volume":"29","author":"MA Papas","year":"2007","unstructured":"Papas MA, Alberg AJ, Ewing R, Helzlsouer KJ, Gary TL, Klassen AC. The built environment and obesity. Epidemiol Rev. 2007;29:129\u201343. https:\/\/doi.org\/10.1093\/epirev\/mxm009.","journal-title":"Epidemiol Rev"},{"key":"3259_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35648-w","volume":"13","author":"C Anza-Ramirez","year":"2022","unstructured":"Anza-Ramirez C, Lazo M, Zafra-Tanaka JH, Avila-Palencia I, Bilal U, Hern\u00e1ndez-V\u00e1squez A, et al. The urban built environment and adult BMI, obesity, and diabetes in Latin American cities. Nat Commun. 2022;13:7977. https:\/\/doi.org\/10.1038\/s41467-022-35648-w.","journal-title":"Nat Commun"},{"key":"3259_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/dar.13596","volume":"42","author":"ED Dimova","year":"2023","unstructured":"Dimova ED, Lekkas P, Maxwell K, Clemens TL, Pearce JR, Mitchell R, et al. Exploring the influence of local alcohol availability on drinking norms and practices: a qualitative scoping review. Drug Alcohol Rev. 2023;42:691\u2013703. https:\/\/doi.org\/10.1111\/dar.13596.","journal-title":"Drug Alcohol Rev"},{"key":"3259_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109352","volume":"233","author":"B Freisthler","year":"2022","unstructured":"Freisthler B, Wernekinck U. Examining how the geographic availability of alcohol within residential neighborhoods, activity spaces, and destination nodes is related to alcohol use by parents of young children. Drug Alcohol Depend. 2022;233:109352. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109352.","journal-title":"Drug Alcohol Depend"},{"key":"3259_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54155-0","volume":"14","author":"MWJ Van Den Ende","year":"2024","unstructured":"Van Den Ende MWJ, Van Der Maas HLJ, Epskamp S, Lees MH. Alcohol consumption as a socially contagious phenomenon in the Framingham Heart Study social network. Sci Rep. 2024;14:4499. https:\/\/doi.org\/10.1038\/s41598-024-54155-0.","journal-title":"Sci Rep"},{"key":"3259_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116006","volume":"329","author":"J Lim","year":"2023","unstructured":"Lim J, Cornwell B. Social network-structural position and obesity: evidence from a national study. Soc Sci Med. 2023;329:116006. https:\/\/doi.org\/10.1016\/j.socscimed.2023.116006.","journal-title":"Soc Sci Med"},{"key":"3259_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1056\/NEJMsa066082","volume":"357","author":"NA Christakis","year":"2007","unstructured":"Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007;357:370\u20139. https:\/\/doi.org\/10.1056\/NEJMsa066082.","journal-title":"N Engl J Med"},{"key":"3259_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41366-023-01331-3","volume":"47","author":"JM Wirtz Baker","year":"2023","unstructured":"Wirtz Baker JM, Pou SA, Niclis C, Haluszka E, Aballay LR. Non-traditional data sources in obesity research: a systematic review of their use in the study of obesogenic environments. Int J Obes (Lond). 2023;47:686\u201396. https:\/\/doi.org\/10.1038\/s41366-023-01331-3.","journal-title":"Int J Obes (Lond)"},{"key":"3259_CR31","doi-asserted-by":"publisher","first-page":"06","DOI":"10.35946\/arcr.v44.1.06","volume":"44","author":"KJ Karriker-Jaffe","year":"2024","unstructured":"Karriker-Jaffe KJ, Goode SA, Blakey SM, Humphrey JL, Williams PA, Borja IR, et al. Area-level social determinants of alcohol-related mortality: knowledge gaps and implications for community health. Alcohol Res. 2024;44:06. https:\/\/doi.org\/10.35946\/arcr.v44.1.06.","journal-title":"Alcohol Res"},{"key":"3259_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.103901","volume":"35","author":"D Capoccia","year":"2025","unstructured":"Capoccia D, Milani I, Colangeli L, Parrotta ME, Leonetti F, Guglielmi V. Social, cultural and ethnic determinants of obesity: from pathogenesis to treatment. Nutr Metab Cardiovasc Dis. 2025;35:103901. https:\/\/doi.org\/10.1016\/j.numecd.2025.103901.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3259_CR33","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41386-018-0203-9","volume":"43","author":"PC Fletcher","year":"2018","unstructured":"Fletcher PC, Kenny PJ. Food addiction: a valid concept? Neuropsychopharmacology. 2018;43:2506\u201313. https:\/\/doi.org\/10.1038\/s41386-018-0203-9.","journal-title":"Neuropsychopharmacology"},{"key":"3259_CR34","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/NMD.0000000000001555","volume":"210","author":"L Florio","year":"2022","unstructured":"Florio L, Lassi DLS, De Azevedo-Marques Perico C, Vignoli NG, Torales J, Ventriglio A, et al. Food addiction: a comprehensive review. J Nerv Ment Dis. 2022;210:874\u20139. https:\/\/doi.org\/10.1097\/NMD.0000000000001555.","journal-title":"J Nerv Ment Dis"},{"key":"3259_CR35","unstructured":"World Health Organization. Alcohol. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/alcohol."},{"key":"3259_CR36","unstructured":"Addolorato G, Mirijello A, Vassallo GA, D\u2019Angelo C, Ferrulli A, Antonelli M, et al. Physical considerations for treatment complications of alcohol and drug use and misuse. In: Johnson B, ed. Addiction medicine. Philadelphia, PA: Elsevier; 2020;pp. 811-32: Chapter 59 (Part IX)."},{"key":"3259_CR37","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1210\/jc.2004-0535","volume":"89","author":"GA Bray","year":"2004","unstructured":"Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583\u20139. https:\/\/doi.org\/10.1210\/jc.2004-0535.","journal-title":"J Clin Endocrinol Metab"},{"key":"3259_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/10408360590913542","volume":"42","author":"PM Suter","year":"2005","unstructured":"Suter PM. Is alcohol consumption a risk factor for weight gain and obesity? Crit Rev Clin Lab Sci. 2005;42:197\u2013227. https:\/\/doi.org\/10.1080\/10408360590913542.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3259_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/ccs3.12039","volume":"18","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen R. The signaling pathways in obesity-related complications. J Cell Commun Signal. 2024;18:e12039. https:\/\/doi.org\/10.1002\/ccs3.12039.","journal-title":"J Cell Commun Signal"},{"key":"3259_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1126\/science.abj5072","volume":"373","author":"CJO O\u2019Brien","year":"2021","unstructured":"O\u2019Brien CJO, Domingos AI. An anti-obesity immunotherapy? Science. 2021;373:24\u201325. https:\/\/doi.org\/10.1126\/science.abj5072.","journal-title":"Science"},{"key":"3259_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bbi.2021.07.023","volume":"97","author":"LR Meredith","year":"2021","unstructured":"Meredith LR, Burnette EM, Grodin EN, Irwin MR, Ray LA. Immune treatments for alcohol use disorder: a translational framework. Brain Behav Immun. 2021;97:349\u201364. https:\/\/doi.org\/10.1016\/j.bbi.2021.07.023.","journal-title":"Brain Behav Immun"},{"key":"3259_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ejim.2007.06.033","volume":"19","author":"L Vonghia","year":"2008","unstructured":"Vonghia L, Leggio L, Ferrulli A, Bertini M, Gasbarrini G, Addolorato G. Acute alcohol intoxication. Eur J Intern Med. 2008;19:561\u20137. https:\/\/doi.org\/10.1016\/j.ejim.2007.06.033.","journal-title":"Eur J Intern Med"},{"key":"3259_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/jan.0000000000000384","volume":"32","author":"LA Farinelli","year":"2021","unstructured":"Farinelli LA, Piacentino D, Browning BD, Brewer BB, Leggio L. Cardiovascular consequences of excessive alcohol drinking via electrocardiogram: a systematic review. J Addict Nurs. 2021;32:39\u201345. https:\/\/doi.org\/10.1097\/jan.0000000000000384.","journal-title":"J Addict Nurs"},{"key":"3259_CR44","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/acer.14386","volume":"44","author":"J Knox","year":"2020","unstructured":"Knox J, Scodes J, Witkiewitz K, Kranzler HR, Mann K, O\u2019Malley SS, et al. Reduction in world health organization risk drinking levels and cardiovascular disease. Alcohol Clin Exp Res. 2020;44:1625\u201335. https:\/\/doi.org\/10.1111\/acer.14386.","journal-title":"Alcohol Clin Exp Res"},{"key":"3259_CR45","doi-asserted-by":"publisher","unstructured":"Wester A, Shang Y, St\u00e5l P, Hagstr\u00f6m H Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: a nationwide cohort study. Hepatol Commun. 2023;7. https:\/\/doi.org\/10.1097\/hc9.0000000000000279.","DOI":"10.1097\/hc9.0000000000000279"},{"key":"3259_CR46","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1097\/hep.0000000000000996","volume":"80","author":"LY Haque","year":"2024","unstructured":"Haque LY, Leggio L. Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder. Hepatology. 2024;80:1408\u201323. https:\/\/doi.org\/10.1097\/hep.0000000000000996.","journal-title":"Hepatology"},{"key":"3259_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41575-021-00527-0","volume":"19","author":"JP Arab","year":"2022","unstructured":"Arab JP, Izzy M, Leggio L, Bataller R, Shah VH. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol. 2022;19:45\u201359. https:\/\/doi.org\/10.1038\/s41575-021-00527-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3259_CR48","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/hep.32531","volume":"77","author":"L Leggio","year":"2023","unstructured":"Leggio L, Mellinger JL. Alcohol use disorder in community management of chronic liver diseases. Hepatology. 2023;77:1006\u201321. https:\/\/doi.org\/10.1002\/hep.32531.","journal-title":"Hepatology"},{"key":"3259_CR49","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/hep.29631","volume":"67","author":"F \u00c5berg","year":"2018","unstructured":"\u00c5berg F, Helenius-Hietala J, Puukka P, F\u00e4rkkil\u00e4 M, Jula A. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population. Hepatology. 2018;67:2141\u20139. https:\/\/doi.org\/10.1002\/hep.29631.","journal-title":"Hepatology"},{"key":"3259_CR50","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/hep.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386. https:\/\/doi.org\/10.1097\/hep.0000000000000520.","journal-title":"Hepatology"},{"key":"3259_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11920-025-01601-z","volume":"27","author":"A Ghanta","year":"2025","unstructured":"Ghanta A, Wilson E, Chao AM. Sex differences in obesity and its treatment. Curr Psychiatry Rep. 2025;27:278\u201385. https:\/\/doi.org\/10.1007\/s11920-025-01601-z.","journal-title":"Curr Psychiatry Rep"},{"key":"3259_CR52","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.neuron.2011.02.016","volume":"69","author":"PJ Kenny","year":"2011","unstructured":"Kenny PJ. Reward mechanisms in obesity: new insights and future directions. Neuron. 2011;69:664\u201379. https:\/\/doi.org\/10.1016\/j.neuron.2011.02.016.","journal-title":"Neuron"},{"key":"3259_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s0091-3057(96)00087-1","volume":"55","author":"P Martel","year":"1996","unstructured":"Martel P, Fantino M. Influence of the amount of food ingested on mesolimbic dopaminergic system activity: a microdialysis study. Pharmacol Biochem Behav. 1996;55:297\u2013302. https:\/\/doi.org\/10.1016\/s0091-3057(96)00087-1.","journal-title":"Pharmacol Biochem Behav"},{"key":"3259_CR54","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neuroscience.2009.02.007","volume":"159","author":"BM Geiger","year":"2009","unstructured":"Geiger BM, Haburcak M, Avena NM, Moyer MC, Hoebel BG, Pothos EN. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience. 2009;159:1193\u20139. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.02.007.","journal-title":"Neuroscience"},{"key":"3259_CR55","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.1239275","volume":"341","author":"LA Tellez","year":"2013","unstructured":"Tellez LA, Medina S, Han W, Ferreira JG, Licona-Lim\u00f3n P, Ren X, et al. A gut lipid messenger links excess dietary fat to dopamine deficiency. Science. 2013;341:800\u20132. https:\/\/doi.org\/10.1126\/science.1239275.","journal-title":"Science"},{"key":"3259_CR56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cmet.2016.12.006","volume":"25","author":"MK Hankir","year":"2017","unstructured":"Hankir MK, Seyfried F, Hintschich CA, Diep TA, Kleberg K, Kranz M, et al. Gastric bypass surgery recruits a Gut PPAR-alpha-striatal D1R pathway to reduce fat appetite in obese rats. Cell Metab. 2017;25:335\u201344. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.006.","journal-title":"Cell Metab"},{"key":"3259_CR57","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/oby.21839","volume":"25","author":"S Sirohi","year":"2017","unstructured":"Sirohi S, Richardson BD, Lugo JM, Rossi DJ, Davis JF. Impact of Roux-en-Y gastric bypass surgery on appetite, alcohol intake behaviors, and midbrain ghrelin signaling in the rat. Obesity (Silver Spring). 2017;25:1228\u201336. https:\/\/doi.org\/10.1002\/oby.21839.","journal-title":"Obesity (Silver Spring)"},{"key":"3259_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neuropharm.2018.08.026","volume":"141","author":"KS Jadhav","year":"2018","unstructured":"Jadhav KS, Peterson VL, Halfon O, Ahern G, Fouhy F, Stanton C, et al. Gut microbiome correlates with altered striatal dopamine receptor expression in a model of compulsive alcohol seeking. Neuropharmacology. 2018;141:249\u201359. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.026.","journal-title":"Neuropharmacology"},{"key":"3259_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/sj.mp.4000859","volume":"6","author":"E Tupala","year":"2001","unstructured":"Tupala E, Hall H, Bergstr\u00f6m K, S\u00e4rkioja T, R\u00e4s\u00e4nen P, Mantere T, et al. Dopamine D(2)\/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Mol Psychiatry. 2001;6:261\u20137. https:\/\/doi.org\/10.1038\/sj.mp.4000859.","journal-title":"Mol Psychiatry"},{"key":"3259_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s1053-8119(03)00060-0","volume":"19","author":"E Tupala","year":"2003","unstructured":"Tupala E, Hall H, Mantere T, R\u00e4s\u00e4nen P, S\u00e4rkioja T, Tiihonen J. Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Neuroimage. 2003;19:145\u201355. https:\/\/doi.org\/10.1016\/s1053-8119(03)00060-0.","journal-title":"Neuroimage"},{"key":"3259_CR61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/bf02245330","volume":"116","author":"J Hietala","year":"1994","unstructured":"Hietala J, West C, Syv\u00e4lahti E, N\u00e5gren K, Lehikoinen P, Sonninen P, et al. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl). 1994;116:285\u201390. https:\/\/doi.org\/10.1007\/bf02245330.","journal-title":"Psychopharmacology (Berl)"},{"key":"3259_CR62","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/j.1530-0277.1996.tb05936.x","volume":"20","author":"ND Volkow","year":"1996","unstructured":"Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res. 1996;20:1594\u20138. https:\/\/doi.org\/10.1111\/j.1530-0277.1996.tb05936.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"3259_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31250-2","volume":"13","author":"G Ribeiro","year":"2023","unstructured":"Ribeiro G, Maia A, Cotovio G, Oliveira FPM, Costa DC, Oliveira-Maia AJ. Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis. Sci Rep. 2023;13:4959. https:\/\/doi.org\/10.1038\/s41598-023-31250-2.","journal-title":"Sci Rep"},{"key":"3259_CR64","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/s0140-6736(00)03643-6","volume":"357","author":"GJ Wang","year":"2001","unstructured":"Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, et al. Brain dopamine and obesity. Lancet. 2001;357:354\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(00)03643-6.","journal-title":"Lancet"},{"key":"3259_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1126\/science.1161550","volume":"322","author":"E Stice","year":"2008","unstructured":"Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science. 2008;322:449\u201352. https:\/\/doi.org\/10.1126\/science.1161550.","journal-title":"Science"},{"key":"3259_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0924-9338(00)00208-x","volume":"15","author":"EP Noble","year":"2000","unstructured":"Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry. 2000;15:79\u201389. https:\/\/doi.org\/10.1016\/s0924-9338(00)00208-x.","journal-title":"Eur Psychiatry"},{"key":"3259_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/aje\/kwm281","volume":"167","author":"L Smith","year":"2008","unstructured":"Smith L, Watson M, Gates S, Ball D, Foxcroft D. Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol. 2008;167:125\u201338. https:\/\/doi.org\/10.1093\/aje\/kwm281.","journal-title":"Am J Epidemiol"},{"key":"3259_CR68","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/2843","volume":"1","author":"TJ Phillips","year":"1998","unstructured":"Phillips TJ, Brown KJ, Burkhart-Kasch S, Wenger CD, Kelly MA, Rubinstein M, et al. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci. 1998;1:610\u20135. https:\/\/doi.org\/10.1038\/2843.","journal-title":"Nat Neurosci"},{"key":"3259_CR69","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.celrep.2019.09.059","volume":"29","author":"ME Bocarsly","year":"2019","unstructured":"Bocarsly ME, da Silva E Silva D, Kolb V, Luderman KD, Shashikiran S, Rubinstein M, et al. A mechanism linking two known vulnerability factors for alcohol abuse: heightened alcohol stimulation and low striatal dopamine D2 receptors. Cell Rep. 2019;29:1147\u20131163.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.09.059.","journal-title":"Cell Rep"},{"key":"3259_CR70","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nn.2519","volume":"13","author":"PM Johnson","year":"2010","unstructured":"Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010;13:635\u201341. https:\/\/doi.org\/10.1038\/nn.2519.","journal-title":"Nat Neurosci"},{"key":"3259_CR71","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.physbeh.2014.02.026","volume":"136","author":"RH Anderberg","year":"2014","unstructured":"Anderberg RH, Anefors C, Bergquist F, Nissbrandt H, Skibicka KP. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior. Physiol Behav. 2014;136:135\u201344. https:\/\/doi.org\/10.1016\/j.physbeh.2014.02.026.","journal-title":"Physiol Behav"},{"key":"3259_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104642","volume":"93","author":"C Aran\u00e4s","year":"2023","unstructured":"Aran\u00e4s C, Edvardsson CE, Shevchouk OT, Zhang Q, Witley S, Blid Sk\u00f6ldheden S, et al. Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats. EBioMedicine. 2023;93:104642. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104642.","journal-title":"EBioMedicine"},{"key":"3259_CR73","doi-asserted-by":"publisher","first-page":"e69010","DOI":"10.1371\/journal.pone.0069010","volume":"8","author":"E Egecioglu","year":"2013","unstructured":"Egecioglu E, Engel JA, Jerlhag E. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLoS ONE. 2013;8:e69010. https:\/\/doi.org\/10.1371\/journal.pone.0069010.","journal-title":"PLoS ONE"},{"key":"3259_CR74","doi-asserted-by":"publisher","first-page":"e77284","DOI":"10.1371\/journal.pone.0077284","volume":"8","author":"E Egecioglu","year":"2013","unstructured":"Egecioglu E, Engel JA, Jerlhag E. The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. PLoS ONE. 2013;8:e77284. https:\/\/doi.org\/10.1371\/journal.pone.0077284.","journal-title":"PLoS ONE"},{"key":"3259_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112466","volume":"42","author":"S Falk","year":"2023","unstructured":"Falk S, Petersen J, Svendsen C, Romero-Leguizam\u00f3n CR, J\u00f8rgensen SH, Krauth N, et al. GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity. Cell Rep. 2023;42:112466. https:\/\/doi.org\/10.1016\/j.celrep.2023.112466.","journal-title":"Cell Rep"},{"key":"3259_CR76","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/npp.2015.220","volume":"41","author":"SM Fortin","year":"2016","unstructured":"Fortin SM, Chartoff EH, Roitman MF. The aversive agent lithium chloride suppresses phasic dopamine release through central GLP-1 receptors. Neuropsychopharmacol. 2016;41:906\u201315. https:\/\/doi.org\/10.1038\/npp.2015.220.","journal-title":"Neuropsychopharmacol"},{"key":"3259_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.physbeh.2017.03.019","volume":"176","author":"SM Fortin","year":"2017","unstructured":"Fortin SM, Roitman MF. Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core. Physiol Behav. 2017;176:17\u201325. https:\/\/doi.org\/10.1016\/j.physbeh.2017.03.019.","journal-title":"Physiol Behav"},{"key":"3259_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112190","volume":"42","author":"R Sandoval-Rodriguez","year":"2023","unstructured":"Sandoval-Rodriguez R, Parra-Reyes JA, Han W, Rueda-Orozco PE, Perez IO, de Araujo IE, et al. D1 and D2 neurons in the nucleus accumbens enable positive and negative control over sugar intake in mice. Cell Rep. 2023;42:112190. https:\/\/doi.org\/10.1016\/j.celrep.2023.112190.","journal-title":"Cell Rep"},{"key":"3259_CR79","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.physbeh.2015.06.013","volume":"149","author":"G Sorensen","year":"2015","unstructured":"Sorensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, et al. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiol Behav. 2015;149:262\u20138. https:\/\/doi.org\/10.1016\/j.physbeh.2015.06.013.","journal-title":"Physiol Behav"},{"key":"3259_CR80","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.psyneuen.2019.02.006","volume":"103","author":"D Vallof","year":"2019","unstructured":"Vallof D, Kalafateli AL, Jerlhag E. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents. Psychoneuroendocrinology. 2019;103:284\u201395. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.02.006.","journal-title":"Psychoneuroendocrinology"},{"key":"3259_CR81","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/adb.12295","volume":"21","author":"D Vallof","year":"2016","unstructured":"Vallof D, Maccioni P, Colombo G, Mandrapa M, J\u00f6rnulf JW, Egecioglu E, et al. The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents. Addict Biol. 2016;21:422\u201337. https:\/\/doi.org\/10.1111\/adb.12295.","journal-title":"Addict Biol"},{"key":"3259_CR82","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.celrep.2015.06.062","volume":"12","author":"XF Wang","year":"2015","unstructured":"Wang XF, Liu JJ, Xia J, Liu J, Mirabella V, Pang ZP. Endogenous Glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons. Cell Rep. 2015;12:726\u201333. https:\/\/doi.org\/10.1016\/j.celrep.2015.06.062.","journal-title":"Cell Rep"},{"key":"3259_CR83","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41386-019-0531-4","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Kahng MW, Elkind JA, Weir VR, Hernandez NS, Stein LM, et al. Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats. Neuropsychopharmacol. 2020;45:451\u201361. https:\/\/doi.org\/10.1038\/s41386-019-0531-4.","journal-title":"Neuropsychopharmacol"},{"key":"3259_CR84","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1146\/annurev-psych-010418-102936","volume":"70","author":"AJ Tomiyama","year":"2019","unstructured":"Tomiyama AJ. Stress and obesity. Annu Rev Psychol. 2019;70:703\u201318. https:\/\/doi.org\/10.1146\/annurev-psych-010418-102936.","journal-title":"Annu Rev Psychol"},{"key":"3259_CR85","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.alcohol.2015.04.004","volume":"49","author":"S Edwards","year":"2015","unstructured":"Edwards S, Little HJ, Richardson HN, Vendruscolo LF. Divergent regulation of distinct glucocorticoid systems in alcohol dependence. Alcohol. 2015;49:811\u20136. https:\/\/doi.org\/10.1016\/j.alcohol.2015.04.004.","journal-title":"Alcohol"},{"key":"3259_CR86","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/bs.irn.2020.11.002","volume":"157","author":"MA McGinn","year":"2021","unstructured":"McGinn MA, Pantazis CB, Tunstall BJ, Marchette RCN, Carlson ER, Said N, et al. Drug addiction co-morbidity with alcohol: neurobiological insights. Int Rev Neurobiol. 2021;157:409\u201372. https:\/\/doi.org\/10.1016\/bs.irn.2020.11.002.","journal-title":"Int Rev Neurobiol"},{"key":"3259_CR87","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3389\/fpsyg.2014.00434","volume":"5","author":"L Sominsky","year":"2014","unstructured":"Sominsky L, Spencer SJ. Eating behavior and stress: a pathway to obesity. Front Psychol. 2014;5:434 https:\/\/doi.org\/10.3389\/fpsyg.2014.00434.","journal-title":"Front Psychol"},{"key":"3259_CR88","doi-asserted-by":"publisher","first-page":"468","DOI":"10.35946\/arcr.v34.4.11","volume":"34","author":"MA Stephens","year":"2012","unstructured":"Stephens MA, Wand G. Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res. 2012;34:468\u201383.","journal-title":"Alcohol Res"},{"key":"3259_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2019.100148","volume":"10","author":"SE Wemm","year":"2019","unstructured":"Wemm SE, Sinha R. Drug-induced stress responses and addiction risk and relapse. Neurobiol Stress. 2019;10:100148. https:\/\/doi.org\/10.1016\/j.ynstr.2019.100148.","journal-title":"Neurobiol Stress"},{"key":"3259_CR90","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/adb.12665","volume":"24","author":"SK Blaine","year":"2019","unstructured":"Blaine SK, Nautiyal N, Hart R, Guarnaccia JB, Sinha R. Craving, cortisol and behavioral alcohol motivation responses to stress and alcohol cue contexts and discrete cues in binge and non-binge drinkers. Addict Biol. 2019;24:1096\u2013108. https:\/\/doi.org\/10.1111\/adb.12665.","journal-title":"Addict Biol"},{"key":"3259_CR91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.biopsycho.2017.05.001","volume":"131","author":"R Sinha","year":"2018","unstructured":"Sinha R. Role of addiction and stress neurobiology on food intake and obesity. Biol Psychol. 2018;131:5\u201313. https:\/\/doi.org\/10.1016\/j.biopsycho.2017.05.001.","journal-title":"Biol Psychol"},{"key":"3259_CR92","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbi.2004.11.004","volume":"19","author":"MF Dallman","year":"2005","unstructured":"Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav Immun. 2005;19:275\u201380. https:\/\/doi.org\/10.1016\/j.bbi.2004.11.004.","journal-title":"Brain Behav Immun"},{"key":"3259_CR93","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.neuron.2023.05.010","volume":"111","author":"CK Ip","year":"2023","unstructured":"Ip CK, Rezitis J, Qi Y, Bajaj N, Koller J, Farzi A, et al. Critical role of lateral habenula circuits in the control of stress-induced palatable food consumption. Neuron. 2023;111:2583\u20132600.e6. https:\/\/doi.org\/10.1016\/j.neuron.2023.05.010.","journal-title":"Neuron"},{"key":"3259_CR94","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.biopsych.2014.09.008","volume":"77","author":"NW Gilpin","year":"2015","unstructured":"Gilpin NW, Herman MA, Roberto M. The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry. 2015;77:859\u201369. https:\/\/doi.org\/10.1016\/j.biopsych.2014.09.008.","journal-title":"Biol Psychiatry"},{"key":"3259_CR95","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1073\/pnas.0437926100","volume":"100","author":"M Roberto","year":"2003","unstructured":"Roberto M, Madamba SG, Moore SD, Tallent MK, Siggins GR. Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sci USA. 2003;100:2053\u20138. https:\/\/doi.org\/10.1073\/pnas.0437926100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3259_CR96","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1126\/science.1092550","volume":"303","author":"Z Nie","year":"2004","unstructured":"Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science. 2004;303:1512\u20134. https:\/\/doi.org\/10.1126\/science.1092550.","journal-title":"Science"},{"key":"3259_CR97","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.neuron.2019.03.037","volume":"102","author":"JA Hardaway","year":"2019","unstructured":"Hardaway JA, Halladay LR, Mazzone CM, Pati D, Bloodgood DW, Kim M, et al. Central amygdala prepronociceptin-expressing neurons mediate palatable food consumption and reward. Neuron. 2019;102:1037\u20131052.e7. https:\/\/doi.org\/10.1016\/j.neuron.2019.03.037.","journal-title":"Neuron"},{"key":"3259_CR98","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1523\/JNEUROSCI.1466-19.2019","volume":"40","author":"ML Torruella-Suarez","year":"2020","unstructured":"Torruella-Suarez ML, Vandenberg JR, Cogan ES, Ipton GJ, Teklezghi A, Dange K, et al. Manipulations of central amygdala neurotensin neurons alter the consumption of ethanol and sweet fluids in mice. J Neurosci. 2020;40:632\u201347. https:\/\/doi.org\/10.1523\/JNEUROSCI.1466-19.2019.","journal-title":"J Neurosci"},{"key":"3259_CR99","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1523\/jneurosci.3096-06.2006","volume":"26","author":"CK Funk","year":"2006","unstructured":"Funk CK, O\u2019Dell LE, Crawford EF, Koob GF. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci. 2006;26:11324\u201332. https:\/\/doi.org\/10.1523\/jneurosci.3096-06.2006.","journal-title":"J Neurosci"},{"key":"3259_CR100","doi-asserted-by":"publisher","first-page":"11316","DOI":"10.1523\/JNEUROSCI.1854-14.2014","volume":"34","author":"MV Micioni Di Bonaventura","year":"2014","unstructured":"Micioni Di Bonaventura MV, Ciccocioppo R, Romano A, Bossert JM, Rice KC, et al. Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction. J Neurosci. 2014;34:11316\u201324. https:\/\/doi.org\/10.1523\/JNEUROSCI.1854-14.2014.","journal-title":"J Neurosci"},{"key":"3259_CR101","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nn1414","volume":"8","author":"EC Dumont","year":"2005","unstructured":"Dumont EC, Mark GP, Mader S, Williams JT. Self-administration enhances excitatory synaptic transmission in the bed nucleus of the stria terminalis. Nat Neurosci. 2005;8:413\u20134. https:\/\/doi.org\/10.1038\/nn1414.","journal-title":"Nat Neurosci"},{"key":"3259_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114343","volume":"43","author":"T Sotelo-Hitschfeld","year":"2024","unstructured":"Sotelo-Hitschfeld T, Minere M, Klemm P, et al. GABAergic disinhibition from the BNST to PNOC(ARC) neurons promotes HFD-induced hyperphagia. Cell Rep. 2024;43:114343. https:\/\/doi.org\/10.1016\/j.celrep.2024.114343.","journal-title":"Cell Rep"},{"key":"3259_CR103","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.neuron.2023.06.006","volume":"111","author":"I de Araujo Salgado","year":"2023","unstructured":"de Araujo Salgado I, Li C, Burnett CJ, Rodriguez Gonzalez S, Becker JJ, et al. Toggling between food-seeking and self-preservation behaviors via hypothalamic response networks. Neuron. 2023;111:2899\u20132917.e6. https:\/\/doi.org\/10.1016\/j.neuron.2023.06.006.","journal-title":"Neuron"},{"key":"3259_CR104","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.celrep.2019.06.051","volume":"28","author":"S Hao","year":"2019","unstructured":"Hao S, Yang H, Wang X, He Y, Xu H, Wu X, et al. The lateral hypothalamic and BNST GABAergic projections to the anterior ventrolateral periaqueductal gray regulate feeding. Cell Rep. 2019;28:616\u2013624.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.06.051.","journal-title":"Cell Rep"},{"key":"3259_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10715-x","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Kim J, Schmit MB, Cho TS, Fang C, Cai H. A bed nucleus of stria terminalis microcircuit regulating inflammation-associated modulation of feeding. Nat Commun. 2019;10:2769. https:\/\/doi.org\/10.1038\/s41467-019-10715-x.","journal-title":"Nat Commun"},{"key":"3259_CR106","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","volume":"4","author":"SC Cork","year":"2015","unstructured":"Cork SC, Richards JE, Holt MK, Gribble FM, Reimann F, Trapp S. Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain. Mol Metab. 2015;4:718\u201331. https:\/\/doi.org\/10.1016\/j.molmet.2015.07.008.","journal-title":"Mol Metab"},{"key":"3259_CR107","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.brainresbull.2019.03.002","volume":"148","author":"H Qiao","year":"2019","unstructured":"Qiao H, Ren WN, Li HZ, Hou YX. Inhibitory effects of peripheral administration of exendin-4 on food intake are attenuated by lesions of the central nucleus of amygdala. Brain Res Bull. 2019;148:131\u20135. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.03.002.","journal-title":"Brain Res Bull"},{"key":"3259_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.724030","volume":"15","author":"N Zeng","year":"2021","unstructured":"Zeng N, Cutts EJ, Lopez CB, Kaur S, Duran M, Virkus SA, et al. Anatomical and functional characterization of central amygdala Glucagon-Like peptide 1 receptor expressing neurons. Front Behav Neurosci. 2021;15:724030. https:\/\/doi.org\/10.3389\/fnbeh.2021.724030.","journal-title":"Front Behav Neurosci"},{"key":"3259_CR109","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13211","volume":"27","author":"M Farokhnia","year":"2022","unstructured":"Farokhnia M, Browning BD, Crozier ME, Sun H, Akhlaghi F, Leggio L. The glucagon-like peptide-1 system is modulated by acute and chronic alcohol exposure: findings from human laboratory experiments and a post-mortem brain study. Addict Biol. 2022;27:e13211. https:\/\/doi.org\/10.1111\/adb.13211.","journal-title":"Addict Biol"},{"key":"3259_CR110","doi-asserted-by":"publisher","unstructured":"Chuong V, Farokhnia M, Khom S, Pince CL, Elvig SK, Vlkolinsky R, et al. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission. JCI Insight. 2023;8. https:\/\/doi.org\/10.1172\/jci.insight.170671.","DOI":"10.1172\/jci.insight.170671"},{"key":"3259_CR111","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1365-2826.2010.01995.x","volume":"22","author":"I Baumgartner","year":"2010","unstructured":"Baumgartner I, Pacheco-Lopez G, Ruttimann EB, Arnold M, Asarian L, Langhans W, et al. Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats. J Neuroendocrinol. 2010;22:557\u201363. https:\/\/doi.org\/10.1111\/j.1365-2826.2010.01995.x.","journal-title":"J Neuroendocrinol"},{"key":"3259_CR112","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/379069a0","volume":"379","author":"MD Turton","year":"1996","unstructured":"Turton MD, O\u2019Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996;379:69\u201372. https:\/\/doi.org\/10.1038\/379069a0.","journal-title":"Nature"},{"key":"3259_CR113","doi-asserted-by":"publisher","first-page":"10470","DOI":"10.1523\/JNEUROSCI.22-23-10470.2002","volume":"22","author":"KP Kinzig","year":"2002","unstructured":"Kinzig KP, D\u2019Alessio DA, Seeley RJ. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci. 2002;22:10470\u20136. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-23-10470.2002.","journal-title":"J Neurosci"},{"key":"3259_CR114","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuropharm.2017.12.007","volume":"131","author":"DL Williams","year":"2018","unstructured":"Williams DL, Lilly NA, Edwards IJ, Yao P, Richards JE, Trapp S. GLP-1 action in the mouse bed nucleus of the stria terminalis. Neuropharmacology. 2018;131:83\u201395. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.007.","journal-title":"Neuropharmacology"},{"issue":"Suppl 5","key":"3259_CR115","doi-asserted-by":"publisher","first-page":"216S","DOI":"10.1038\/oby.2006.312","volume":"14","author":"HJ Grill","year":"2006","unstructured":"Grill HJ. Distributed neural control of energy balance: contributions from hindbrain and hypothalamus. Obesity (Silver Spring). 2006;14(Suppl 5):216S\u2013221S. https:\/\/doi.org\/10.1038\/oby.2006.312.","journal-title":"Obesity (Silver Spring)"},{"key":"3259_CR116","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cell.2015.01.003","volume":"160","author":"EH Nieh","year":"2015","unstructured":"Nieh EH, Matthews GA, Allsop SA, Presbrey KN, Leppla CA, Wichmann R, et al. Decoding neural circuits that control compulsive sucrose seeking. Cell. 2015;160:528\u201341. https:\/\/doi.org\/10.1016\/j.cell.2015.01.003.","journal-title":"Cell"},{"key":"3259_CR117","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1523\/JNEUROSCI.1202-15.2016","volume":"36","author":"AM Stamatakis","year":"2016","unstructured":"Stamatakis AM, Van Swieten M, Basiri ML, Blair GA, Kantak P, Stuber GD. Lateral hypothalamic area glutamatergic neurons and their projections to the lateral habenula regulate feeding and reward. J Neurosci. 2016;36:302\u201311. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-15.2016.","journal-title":"J Neurosci"},{"key":"3259_CR118","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cmet.2017.09.021","volume":"27","author":"MA Rossi","year":"2018","unstructured":"Rossi MA, Stuber GD. Overlapping brain circuits for homeostatic and hedonic feeding. Cell Metab. 2018;27:42\u201356. https:\/\/doi.org\/10.1016\/j.cmet.2017.09.021.","journal-title":"Cell Metab"},{"key":"3259_CR119","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1126\/science.aax1184","volume":"364","author":"MA Rossi","year":"2019","unstructured":"Rossi MA, Basiri ML, McHenry JA, Kosyk O, Otis JM, van den Munkhof HE, et al. Obesity remodels activity and transcriptional state of a lateral hypothalamic brake on feeding. Science. 2019;364:1271\u20134. https:\/\/doi.org\/10.1126\/science.aax1184.","journal-title":"Science"},{"key":"3259_CR120","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1126\/science.1241812","volume":"341","author":"JH Jennings","year":"2013","unstructured":"Jennings JH, Rizzi G, Stamatakis AM, Ung RL, Stuber GD. The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding. Science. 2013;341:1517\u201321. https:\/\/doi.org\/10.1126\/science.1241812.","journal-title":"Science"},{"key":"3259_CR121","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/oby.21109","volume":"23","author":"WJ Eiler 2nd","year":"2015","unstructured":"Eiler WJ 2nd, Dzemidzic M, Case KR, Soeurt CM, Armstrong CL, et al. The aperitif effect: alcohol\u2019s effects on the brain\u2019s response to food aromas in women. Obesity (Silver Spring). 2015;23:1386\u201393. https:\/\/doi.org\/10.1002\/oby.21109.","journal-title":"Obesity (Silver Spring)"},{"key":"3259_CR122","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.pnpbp.2015.02.006","volume":"65","author":"JR Barson","year":"2016","unstructured":"Barson JR, Leibowitz SF. Hypothalamic neuropeptide signaling in alcohol addiction. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:321\u20139. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.02.006.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3259_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107991","volume":"167","author":"VN Marty","year":"2020","unstructured":"Marty VN, Mulpuri Y, Munier JJ, Spigelman I. Chronic alcohol disrupts hypothalamic responses to stress by modifying CRF and NMDA receptor function. Neuropharmacology. 2020;167:107991. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107991.","journal-title":"Neuropharmacology"},{"key":"3259_CR124","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/mp.2017.226","volume":"23","author":"M Farokhnia","year":"2018","unstructured":"Farokhnia M, Grodin EN, Lee MR, Oot EN, Blackburn AN, Stangl BL, et al. Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals. Mol Psychiatry. 2018;23:2029\u201338. https:\/\/doi.org\/10.1038\/mp.2017.226.","journal-title":"Mol Psychiatry"},{"key":"3259_CR125","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0091-3057(02)00780-3","volume":"73","author":"MJ Wayner","year":"2002","unstructured":"Wayner MJ. Craving for alcohol in the rat: adjunctive behavior and the lateral hypothalamus. Pharmacol Biochem Behav. 2002;73:27\u201343. https:\/\/doi.org\/10.1016\/s0091-3057(02)00780-3.","journal-title":"Pharmacol Biochem Behav"},{"key":"3259_CR126","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1523\/JNEUROSCI.0256-14.2014","volume":"34","author":"NJ Marchant","year":"2014","unstructured":"Marchant NJ, Rabei R, Kaganovsky K, Caprioli D, Bossert JM, Bonci A, et al. A critical role of lateral hypothalamus in context-induced relapse to alcohol seeking after punishment-imposed abstinence. J Neurosci. 2014;34:7447\u201357. https:\/\/doi.org\/10.1523\/JNEUROSCI.0256-14.2014.","journal-title":"J Neurosci"},{"key":"3259_CR127","first-page":"15","volume":"18","author":"LW Greene","year":"1981","unstructured":"Greene LW, Hollander CS. Alcohol and the hypothalamus. Prog Biochem Pharmacol. 1981;18:15\u201323.","journal-title":"Prog Biochem Pharmacol"},{"key":"3259_CR128","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/0269881120959638","volume":"34","author":"EJ Campbell","year":"2020","unstructured":"Campbell EJ, Hill MK, Maddern XJ, Jin S, Pang TY, Lawrence AJ. Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking. J Psychopharmacol. 2020;34:1261\u201370. https:\/\/doi.org\/10.1177\/0269881120959638.","journal-title":"J Psychopharmacol"},{"key":"3259_CR129","doi-asserted-by":"publisher","unstructured":"Colvin KJ, Killen HS, Kanter MJ, Halperin MC, Engel L, Currie PJ Brain site-specific inhibitory effects of the GLP-1 analogue Exendin-4 on alcohol intake and operant responding for palatable food. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21249710.","DOI":"10.3390\/ijms21249710"},{"key":"3259_CR130","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1210\/en.2014-1248","volume":"155","author":"JE Richard","year":"2014","unstructured":"Richard JE, Farkas I, Anesten F, Anderberg RH, Dickson SL, Gribble FM, et al. GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence. Endocrinology. 2014;155:4356\u201367. https:\/\/doi.org\/10.1210\/en.2014-1248.","journal-title":"Endocrinology"},{"key":"3259_CR131","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/mp.2017.187","volume":"23","author":"L Lopez-Ferreras","year":"2018","unstructured":"Lopez-Ferreras L, Richard JE, Noble EE, Eerola K, Anderberg RH, Olandersson K, et al. Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight. Mol Psychiatry. 2018;23:1157\u201368. https:\/\/doi.org\/10.1038\/mp.2017.187.","journal-title":"Mol Psychiatry"},{"key":"3259_CR132","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/db16-1102","volume":"66","author":"MA Burmeister","year":"2017","unstructured":"Burmeister MA, Ayala JE, Smouse H, Landivar-Rocha A, Brown JD, Drucker DJ, et al. The hypothalamic Glucagon-Like peptide 1 receptor is sufficient but not necessary for the regulation of energy balance and glucose homeostasis in mice. Diabetes. 2017;66:372\u201384. https:\/\/doi.org\/10.2337\/db16-1102.","journal-title":"Diabetes"},{"key":"3259_CR133","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s42255-022-00606-9","volume":"4","author":"W Cheng","year":"2022","unstructured":"Cheng W, Gordian D, Ludwig MQ, Pers TH, Seeley RJ, Myers MG Jr. Hindbrain circuits in the control of eating behaviour and energy balance. Nat Metab. 2022;4:826\u201335. https:\/\/doi.org\/10.1038\/s42255-022-00606-9.","journal-title":"Nat Metab"},{"key":"3259_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101240","volume":"53","author":"GKC Dowsett","year":"2021","unstructured":"Dowsett GKC, Lam BYH, Tadross JA, Cimino I, Rimmington D, Coll AP, et al. A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing. Mol Metab. 2021;53:101240. https:\/\/doi.org\/10.1016\/j.molmet.2021.101240.","journal-title":"Mol Metab"},{"key":"3259_CR135","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","volume":"3","author":"MQ Ludwig","year":"2021","unstructured":"Ludwig MQ, Cheng W, Gordian D, Lee J, Paulsen SJ, Hansen SN, et al. A genetic map of the mouse dorsal vagal complex and its role in obesity. Nat Metab. 2021;3:530\u201345. https:\/\/doi.org\/10.1038\/s42255-021-00363-1.","journal-title":"Nat Metab"},{"key":"3259_CR136","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","volume":"109","author":"C Zhang","year":"2021","unstructured":"Zhang C, Kaye JA, Cai Z, Wang Y, Prescott SL, Liberles SD. Area postrema cell types that mediate nausea-associated behaviors. Neuron. 2021;109:461\u2013472.e5. https:\/\/doi.org\/10.1016\/j.neuron.2020.11.010.","journal-title":"Neuron"},{"key":"3259_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25525-3","volume":"12","author":"W Cheng","year":"2021","unstructured":"Cheng W, Ndoka E, Maung JN, Pan W, Rupp AC, Rhodes CJ, et al. NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity. Nat Commun. 2021;12:5175. https:\/\/doi.org\/10.1038\/s41467-021-25525-3.","journal-title":"Nat Commun"},{"key":"3259_CR138","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017;550:255\u20139. https:\/\/doi.org\/10.1038\/nature24042.","journal-title":"Nature"},{"key":"3259_CR139","doi-asserted-by":"publisher","first-page":"R575","DOI":"10.1152\/ajpregu.1986.251.3.R575","volume":"251","author":"GL Edwards","year":"1986","unstructured":"Edwards GL, Ritter RC. Area postrema lesions: cause of overingestion is not altered visceral nerve function. Am J Physiol. 1986;251:R575\u201381. https:\/\/doi.org\/10.1152\/ajpregu.1986.251.3.R575.","journal-title":"Am J Physiol"},{"key":"3259_CR140","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1530-0277.1988.tb00268.x","volume":"12","author":"RB Stewart","year":"1988","unstructured":"Stewart RB, Perlanski E, Grupp LA. Area postrema and alcohol: effects of area postrema lesions on ethanol self-administration, pharmacokinetics, and ethanol-induced conditioned taste aversion. Alcohol Clin Exp Res. 1988;12:698\u2013704. https:\/\/doi.org\/10.1111\/j.1530-0277.1988.tb00268.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"3259_CR141","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nn.4540","volume":"20","author":"LM Tuesta","year":"2017","unstructured":"Tuesta LM, Chen Z, Duncan A, Fowler CD, Ishikawa M, Lee BR, et al. GLP-1 acts on habenular avoidance circuits to control nicotine intake. Nat Neurosci. 2017;20:708\u201316. https:\/\/doi.org\/10.1038\/nn.4540.","journal-title":"Nat Neurosci"},{"key":"3259_CR142","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","volume":"18","author":"AJ Kastin","year":"2002","unstructured":"Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci. 2002;18:7\u201314. https:\/\/doi.org\/10.1385\/JMN:18:1-2:07.","journal-title":"J Mol Neurosci"},{"key":"3259_CR143","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","volume":"403","author":"I Merchenthaler","year":"1999","unstructured":"Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol. 1999;403:261\u201380.","journal-title":"J Comp Neurol"},{"key":"3259_CR144","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0306-4522(96)00434-4","volume":"77","author":"PJ Larsen","year":"1997","unstructured":"Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 1997;77:257\u201370. https:\/\/doi.org\/10.1016\/s0306-4522(96)00434-4.","journal-title":"Neuroscience"},{"key":"3259_CR145","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2337\/db18-0729","volume":"68","author":"MK Holt","year":"2019","unstructured":"Holt MK, Richards JE, Cook DR, Brierley DI, Williams DL, Reimann F, et al. Preproglucagon neurons in the nucleus of the solitary tract are the main source of brain GLP-1, mediate stress-induced hypophagia, and limit unusually large intakes of food. Diabetes. 2019;68:21\u201333. https:\/\/doi.org\/10.2337\/db18-0729.","journal-title":"Diabetes"},{"key":"3259_CR146","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","volume":"632","author":"KP Huang","year":"2024","unstructured":"Huang KP, Acosta AA, Ghidewon MY, McKnight AD, Almeida MS, Nyema NT, et al. Dissociable hindbrain GLP1R circuits for satiety and aversion. Nature. 2024;632:585\u201393. https:\/\/doi.org\/10.1038\/s41586-024-07685-6.","journal-title":"Nature"},{"key":"3259_CR147","doi-asserted-by":"publisher","unstructured":"Hayashi M, Kaye JA, Douglas ER, Joshi NR, Gribble FM, Reimann F, et al. Enteroendocrine cell lineages that differentially control feeding and gut motility. Elife. 2023;12 https:\/\/doi.org\/10.7554\/eLife.78512.","DOI":"10.7554\/eLife.78512"},{"key":"3259_CR148","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1126\/science.adl1460","volume":"386","author":"J Beumer","year":"2024","unstructured":"Beumer J, Geurts MH, Geurts V, Andersson-Rolf A, Akkerman N, V\u00f6llmy F, et al. Description and functional validation of human enteroendocrine cell sensors. Science. 2024;386:341\u20138. https:\/\/doi.org\/10.1126\/science.adl1460.","journal-title":"Science"},{"key":"3259_CR149","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/00365529409092462","volume":"29","author":"A Wettergren","year":"1994","unstructured":"Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol. 1994;29:501\u20135. https:\/\/doi.org\/10.3109\/00365529409092462.","journal-title":"Scand J Gastroenterol"},{"key":"3259_CR150","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.cell.2019.10.031","volume":"179","author":"L Bai","year":"2019","unstructured":"Bai L, Mesgarzadeh S, Ramesh KS, Huey EL, Liu Y, Gray LA, et al. Genetic identification of vagal sensory neurons that control feeding. Cell. 2019;179:1129\u20131143.e23. https:\/\/doi.org\/10.1016\/j.cell.2019.10.031.","journal-title":"Cell"},{"key":"3259_CR151","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s42255-021-00344-4","volume":"3","author":"DI Brierley","year":"2021","unstructured":"Brierley DI, Holt MK, Singh A, de Araujo A, McDougle M, Vergara M, et al. Central and peripheral GLP-1 systems independently suppress eating. Nat Metab. 2021;3:258\u201373. https:\/\/doi.org\/10.1038\/s42255-021-00344-4.","journal-title":"Nat Metab"},{"key":"3259_CR152","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.regpep.2009.03.002","volume":"155","author":"DH Kim","year":"2009","unstructured":"Kim DH, D\u2019Alessio DA, Woods SC, Seeley RJ. The effects of GLP-1 infusion in the hepatic portal region on food intake. Regul Pept. 2009;155:110\u20134. https:\/\/doi.org\/10.1016\/j.regpep.2009.03.002.","journal-title":"Regul Pept"},{"key":"3259_CR153","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1210\/en.2008-1221","volume":"150","author":"EB Ruttimann","year":"2009","unstructured":"Ruttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology. 2009;150:1174\u201381. https:\/\/doi.org\/10.1210\/en.2008-1221.","journal-title":"Endocrinology"},{"key":"3259_CR154","doi-asserted-by":"publisher","first-page":"G342","DOI":"10.1152\/ajpgi.00095.2017","volume":"313","author":"C Diepenbroek","year":"2017","unstructured":"Diepenbroek C, Quinn D, Stephens R, Zollinger B, Anderson S, Pan A, et al. Validation and characterization of a novel method for selective vagal deafferentation of the gut. Am J Physiol Gastrointest Liver Physiol. 2017;313:G342\u2013G352. https:\/\/doi.org\/10.1152\/ajpgi.00095.2017.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3259_CR155","doi-asserted-by":"publisher","first-page":"G1117","DOI":"10.1152\/ajpgi.00035.2013","volume":"304","author":"A Plamboeck","year":"2013","unstructured":"Plamboeck A, Veedfald S, Deacon CF, Hartmann B, Wettergren A, Svendsen LB, et al. The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty. Am J Physiol Gastrointest Liver Physiol. 2013;304:G1117\u201327. https:\/\/doi.org\/10.1152\/ajpgi.00035.2013.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3259_CR156","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1210\/en.2011-0174","volume":"152","author":"SE Kanoski","year":"2011","unstructured":"Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology. 2011;152:3103\u201312. https:\/\/doi.org\/10.1210\/en.2011-0174.","journal-title":"Endocrinology"},{"key":"3259_CR157","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","volume":"1044","author":"CR Abbott","year":"2005","unstructured":"Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005;1044:127\u201331. https:\/\/doi.org\/10.1016\/j.brainres.2005.03.011.","journal-title":"Brain Res"},{"key":"3259_CR158","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.7233218","volume":"212","author":"MF Gonzalez","year":"1981","unstructured":"Gonzalez MF, Deutsch JA. Vagotomy abolishes cues of satiety produced by gastric distension. Science. 1981;212:1283\u20134. https:\/\/doi.org\/10.1126\/science.7233218.","journal-title":"Science"},{"key":"3259_CR159","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.cmet.2021.05.002","volume":"33","author":"D Borgmann","year":"2021","unstructured":"Borgmann D, Ciglieri E, Biglari N, Brandt C, Cremer AL, Backes H, et al. Gut-brain communication by distinct sensory neurons differently controls feeding and glucose metabolism. Cell Metab. 2021;33:1466\u20131482.e7. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.002.","journal-title":"Cell Metab"},{"key":"3259_CR160","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1113\/jphysiol.2010.204594","volume":"589","author":"DM Daly","year":"2011","unstructured":"Daly DM, Park SJ, Valinsky WC, Beyak MJ. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol. 2011;589:2857\u201370. https:\/\/doi.org\/10.1113\/jphysiol.2010.204594.","journal-title":"J Physiol"},{"key":"3259_CR161","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1566-0702(00)00176-4","volume":"84","author":"M Covasa","year":"2000","unstructured":"Covasa M, Grahn J, Ritter RC. Reduced hindbrain and enteric neuronal response to intestinal oleate in rats maintained on high-fat diet. Auton Neurosci. 2000;84:8\u201318. https:\/\/doi.org\/10.1016\/S1566-0702(00)00176-4.","journal-title":"Auton Neurosci"},{"key":"3259_CR162","doi-asserted-by":"publisher","first-page":"R279","DOI":"10.1152\/ajpregu.1999.277.1.R279","volume":"277","author":"M Covasa","year":"1999","unstructured":"Covasa M, Ritter RC. Reduced sensitivity to the satiation effect of intestinal oleate in rats adapted to high-fat diet. Am J Physiol. 1999;277:R279\u201385. https:\/\/doi.org\/10.1152\/ajpregu.1999.277.1.R279.","journal-title":"Am J Physiol"},{"key":"3259_CR163","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/acer.15264","volume":"48","author":"BN Keller","year":"2024","unstructured":"Keller BN, Snyder AE, Coker CR, Aguilar EA, O\u2019Brien MK, Lookfong NA, et al. Vagus nerve damage increases alcohol intake and preference in a nonpreferring rat line: relationship to vagal regulation of the hypothalamic-pituitary-adrenal axis. Alcohol Clin Exp Res (Hoboken). 2024;48:488\u201398. https:\/\/doi.org\/10.1111\/acer.15264.","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"3259_CR164","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neubiorev.2021.06.031","volume":"128","author":"J Zeng","year":"2021","unstructured":"Zeng J, Yu S, Cao H, Su Y, Dong Z, Yang X. Neurobiological correlates of cue-reactivity in alcohol-use disorders: a voxel-wise meta-analysis of fMRI studies. Neurosci Biobehav Rev. 2021;128:294\u2013310. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.06.031.","journal-title":"Neurosci Biobehav Rev"},{"key":"3259_CR165","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s13679-017-0289-0","volume":"6","author":"ME Gluck","year":"2017","unstructured":"Gluck ME, Viswanath P, Stinson EJ. Obesity, appetite, and the prefrontal cortex. Curr Obes Rep. 2017;6:380\u20138. https:\/\/doi.org\/10.1007\/s13679-017-0289-0.","journal-title":"Curr Obes Rep"},{"key":"3259_CR166","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41386-021-01132-0","volume":"47","author":"NP Friedman","year":"2022","unstructured":"Friedman NP, Robbins TW. The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacol. 2022;47:72\u201389. https:\/\/doi.org\/10.1038\/s41386-021-01132-0.","journal-title":"Neuropsychopharmacol"},{"key":"3259_CR167","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fendo.2017.00127","volume":"8","author":"A Michaud","year":"2017","unstructured":"Michaud A, Vainik U, Garcia-Garcia I, Dagher A. Overlapping neural endophenotypes in addiction and obesity. Front Endocrinol (Lausanne). 2017;8:127. https:\/\/doi.org\/10.3389\/fendo.2017.00127.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3259_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2021.113540","volume":"240","author":"DM Eichen","year":"2021","unstructured":"Eichen DM, Pasquale EK, Twamley EW, Boutelle KN. Targeting executive function for weight loss in adults with overweight or obesity. Physiol Behav. 2021;240:113540. https:\/\/doi.org\/10.1016\/j.physbeh.2021.113540.","journal-title":"Physiol Behav"},{"key":"3259_CR169","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.appet.2014.03.014","volume":"78","author":"H Veling","year":"2014","unstructured":"Veling H, van Koningsbruggen GM, Aarts H, Stroebe W. Targeting impulsive processes of eating behavior via the internet. Effects on body weight. Appetite. 2014;78:102\u20139. https:\/\/doi.org\/10.1016\/j.appet.2014.03.014.","journal-title":"Appetite"},{"key":"3259_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/revneuro-2013-0054","volume":"25","author":"CE Wilcox","year":"2014","unstructured":"Wilcox CE, Dekonenko CJ, Mayer AR, Bogenschutz MP, Turner JA. Cognitive control in alcohol use disorder: deficits and clinical relevance. Rev Neurosci. 2014;25:1\u201324. https:\/\/doi.org\/10.1515\/revneuro-2013-0054.","journal-title":"Rev Neurosci"},{"key":"3259_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2021.152257","volume":"109","author":"R Maatoug","year":"2021","unstructured":"Maatoug R, Bihan K, Duriez P, Podevin P, Silveira-Reis-Brito L, Benyamina A, et al. Non-invasive and invasive brain stimulation in alcohol use disorders: a critical review of selected human evidence and methodological considerations to guide future research. Compr Psychiatry. 2021;109:152257. https:\/\/doi.org\/10.1016\/j.comppsych.2021.152257.","journal-title":"Compr Psychiatry"},{"key":"3259_CR172","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12611","volume":"13","author":"YA Alhindi","year":"2023","unstructured":"Alhindi YA, Khalifa N, Al-Khyatt W, Idris I. The use of non-invasive brain stimulation techniques to reduce body weight and food cravings: a systematic review and meta-analysis. Clin Obes. 2023;13:e12611. https:\/\/doi.org\/10.1111\/cob.12611.","journal-title":"Clin Obes"},{"key":"3259_CR173","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1369-1600.2012.00464.x","volume":"18","author":"JP Schacht","year":"2013","unstructured":"Schacht JP, Anton RF, Myrick H. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta\u2010analysis and systematic review. Addict Biol. 2013;18:121\u201333. https:\/\/doi.org\/10.1111\/j.1369-1600.2012.00464.x.","journal-title":"Addict Biol"},{"key":"3259_CR174","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.euroneuro.2016.06.013","volume":"26","author":"HR Noori","year":"2016","unstructured":"Noori HR, Cosa Linan A, Spanagel R. Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: a comprehensive meta-analysis. Eur Neuropsychopharmacol. 2016;26:1419\u201330. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.06.013.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3259_CR175","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/brainsci11121587","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wu Q, Morys F. Brain responses to high-calorie visual food cues in individuals with normal-weight or obesity: an activation likelihood estimation meta-analysis. Brain Sci. 2021;11:1587. https:\/\/doi.org\/10.3390\/brainsci11121587.","journal-title":"Brain Sci"},{"key":"3259_CR176","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuroimage.2010.11.055","volume":"55","author":"LN Van Der Laan","year":"2011","unstructured":"Van Der Laan LN, De Ridder DTD, Viergever MA, Smeets PAM. The first taste is always with the eyes: a meta-analysis on the neural correlates of processing visual food cues. Neuroimage. 2011;55:296\u2013303. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.11.055.","journal-title":"Neuroimage"},{"key":"3259_CR177","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.physbeh.2012.03.009","volume":"106","author":"DW Tang","year":"2012","unstructured":"Tang DW, Fellows LK, Small DM, Dagher A. Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies. Physiol Behav. 2012;106:317\u201324. https:\/\/doi.org\/10.1016\/j.physbeh.2012.03.009.","journal-title":"Physiol Behav"},{"key":"3259_CR178","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41380-023-02025-y","volume":"28","author":"G Li","year":"2023","unstructured":"Li G, Hu Y, Zhang W, et al. Brain functional and structural magnetic resonance imaging of obesity and weight loss interventions. Mol Psychiatry. 2023;28:1466\u201379. https:\/\/doi.org\/10.1038\/s41380-023-02025-y.","journal-title":"Mol Psychiatry"},{"key":"3259_CR179","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1124\/pharmrev.120.000191","volume":"73","author":"I Fredriksson","year":"2021","unstructured":"Fredriksson I, Venniro M, Reiner DJ, Chow JJ, Bossert JM, Shaham Y. Animal models of drug relapse and craving after voluntary abstinence: a review. Pharmacol Rev. 2021;73:1050\u201383. https:\/\/doi.org\/10.1124\/pharmrev.120.000191.","journal-title":"Pharmacol Rev"},{"key":"3259_CR180","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41583-020-0378-z","volume":"21","author":"M Venniro","year":"2020","unstructured":"Venniro M, Banks ML, Heilig M, Epstein DH, Shaham Y. Improving translation of animal models of addiction and relapse by reverse translation. Nat Rev Neurosci. 2020;21:625\u201343. https:\/\/doi.org\/10.1038\/s41583-020-0378-z.","journal-title":"Nat Rev Neurosci"},{"key":"3259_CR181","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/npp.2016.128","volume":"42","author":"JA Avery","year":"2017","unstructured":"Avery JA, Burrows K, Kerr KL, Bodurka J, Khalsa SS, Paulus MP, et al. How the brain wants what the body needs: the neural basis of positive alliesthesia. Neuropsychopharmacol. 2017;42:822\u201330. https:\/\/doi.org\/10.1038\/npp.2016.128.","journal-title":"Neuropsychopharmacol"},{"key":"3259_CR182","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41593-022-01228-w","volume":"26","author":"L Koban","year":"2023","unstructured":"Koban L, Wager TD, Kober H. A neuromarker for drug and food craving distinguishes drug users from non-users. Nat Neurosci. 2023;26:316\u201325. https:\/\/doi.org\/10.1038\/s41593-022-01228-w.","journal-title":"Nat Neurosci"},{"key":"3259_CR183","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/alcalc\/agaa050","volume":"55","author":"JF Kelly","year":"2020","unstructured":"Kelly JF, Abry A, Ferri M, Humphreys K. Alcoholics anonymous and 12-step facilitation treatments for alcohol use disorder: a distillation of a 2020 cochrane review for clinicians and policy makers. Alcohol Alcohol. 2020;55:641\u201351. https:\/\/doi.org\/10.1093\/alcalc\/agaa050.","journal-title":"Alcohol Alcohol"},{"key":"3259_CR184","doi-asserted-by":"publisher","unstructured":"McCrady BS, Owens MD, Borders AZ, Brovko JM Psychosocial approaches to alcohol use disorders since 1940: a review. J Stud Alcohol Drugs Suppl. 2014:68-78. https:\/\/doi.org\/10.15288\/jsads.2014.s17.68.","DOI":"10.15288\/jsads.2014.s17.68"},{"key":"3259_CR185","first-page":"313","volume":"33","author":"K Witkiewitz","year":"2011","unstructured":"Witkiewitz K, Marlatt A. Behavioral therapy across the spectrum. Alcohol Res Health. 2011;33:313\u20139.","journal-title":"Alcohol Res Health"},{"key":"3259_CR186","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4043","volume":"5","author":"K Witkiewitz","year":"2019","unstructured":"Witkiewitz K, Litten RZ, Leggio L. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019;5:eaax4043. https:\/\/doi.org\/10.1126\/sciadv.aax4043.","journal-title":"Sci Adv"},{"key":"3259_CR187","doi-asserted-by":"crossref","unstructured":"L\u00e9k\u00f3 AH, Farokhnia M, Leggio L. Approved, promising, and experimental medications for treatment of alcohol use disorder. In: Mueller S, Heilig M, eds. Alcohol and alcohol-related diseases. Cham, Switzerland: Springer International Publishing; 2023. pp. 261-88.","DOI":"10.1007\/978-3-031-32483-3_16"},{"key":"3259_CR188","doi-asserted-by":"publisher","unstructured":"Heilig M, Witkiewitz K, Ray LA, Leggio L Novel medications for problematic alcohol use. J Clin Invest. 2024;134. https:\/\/doi.org\/10.1172\/jci172889.","DOI":"10.1172\/jci172889"},{"key":"3259_CR189","doi-asserted-by":"publisher","first-page":"e208279","DOI":"10.1001\/jamanetworkopen.2020.8279","volume":"3","author":"LA Ray","year":"2020","unstructured":"Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e208279. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.8279.","journal-title":"JAMA Netw Open"},{"key":"3259_CR190","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.appet.2007.05.006","volume":"50","author":"J Cowan","year":"2008","unstructured":"Cowan J, Devine C. Food, eating, and weight concerns of men in recovery from substance addiction. Appetite. 2008;50:33\u201342. https:\/\/doi.org\/10.1016\/j.appet.2007.05.006.","journal-title":"Appetite"},{"key":"3259_CR191","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/10826084.2018.1536722","volume":"54","author":"NC Gottfredson","year":"2019","unstructured":"Gottfredson NC, Sokol RL. Explaining excessive weight gain during early recovery from addiction. Subst Use Misuse. 2019;54:769\u201378. https:\/\/doi.org\/10.1080\/10826084.2018.1536722.","journal-title":"Subst Use Misuse"},{"key":"3259_CR192","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1080\/10826080701517727","volume":"42","author":"LJ Nolan","year":"2007","unstructured":"Nolan LJ, Scagnelli LM. Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenance. Subst Use Misuse. 2007;42:1555\u201366. https:\/\/doi.org\/10.1080\/10826080701517727.","journal-title":"Subst Use Misuse"},{"key":"3259_CR193","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/m14-2238","volume":"162","author":"KA Gudzune","year":"2015","unstructured":"Gudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162:501\u201312. https:\/\/doi.org\/10.7326\/m14-2238.","journal-title":"Ann Intern Med"},{"key":"3259_CR194","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","volume":"25","author":"Diabetes Prevention Program (DPP) Research Group","year":"2002","unstructured":"Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165\u201371. https:\/\/doi.org\/10.2337\/diacare.25.12.2165.","journal-title":"Diabetes Care"},{"key":"3259_CR195","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity management in adults: a review. JAMA. 2023;330:2000\u201315. https:\/\/doi.org\/10.1001\/jama.2023.19897.","journal-title":"JAMA"},{"key":"3259_CR196","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jamainternmed.2023.8526","volume":"184","author":"SZ Yanovski","year":"2024","unstructured":"Yanovski SZ, Yanovski JA. Approach to obesity treatment in primary care: a review. JAMA Intern Med. 2024;184:818\u201329. https:\/\/doi.org\/10.1001\/jamainternmed.2023.8526.","journal-title":"JAMA Intern Med"},{"key":"3259_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107312","volume":"207","author":"N Bruns Vi","year":"2024","unstructured":"Bruns Vi N, Tressler EH, Vendruscolo LF, Leggio L, Farokhnia M. IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target. Pharmacol Res. 2024;207:107312. https:\/\/doi.org\/10.1016\/j.phrs.2024.107312.","journal-title":"Pharmacol Res"},{"key":"3259_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101351","volume":"57","author":"DJ Drucker","year":"2022","unstructured":"Drucker DJ. GLP-1 physiology informs the pharmacotherapy of obesity. Mol Metab. 2022;57:101351. https:\/\/doi.org\/10.1016\/j.molmet.2021.101351.","journal-title":"Mol Metab"},{"key":"3259_CR199","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jamasurg.2024.1502","volume":"159","author":"JM Samuels","year":"2024","unstructured":"Samuels JM, Patel MB, Niswender KD. Time to rethink the approach to treating obesity. JAMA Surg. 2024;159:841\u20132. https:\/\/doi.org\/10.1001\/jamasurg.2024.1502.","journal-title":"JAMA Surg"},{"key":"3259_CR200","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of Glucagon-like peptide 1. Physiol Rev. 2007;87:1409\u201339. https:\/\/doi.org\/10.1152\/physrev.00034.2006.","journal-title":"Physiol Rev"},{"key":"3259_CR201","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"LB Knudsen","year":"2019","unstructured":"Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne). 2019;10:155. https:\/\/doi.org\/10.3389\/fendo.2019.00155.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3259_CR202","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1056\/NEJMcibr2409089","volume":"392","author":"DJ Drucker","year":"2025","unstructured":"Drucker DJ. Discovery of GLP-1-based drugs for the treatment of obesity. N Engl J Med. 2025;392:612\u20135. https:\/\/doi.org\/10.1056\/NEJMcibr2409089.","journal-title":"N Engl J Med"},{"key":"3259_CR203","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa2301972","volume":"389","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff AM, Kaplan LM, Fr\u00edas JP, Wu Q, Du Y, Gurbuz S, et al. Triple\u2013hormone-receptor agonist retatrutide for obesity \u2014 a phase 2 trial. N Engl J Med. 2023;389:514\u201326. https:\/\/doi.org\/10.1056\/NEJMoa2301972.","journal-title":"N Engl J Med"},{"key":"3259_CR204","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/bph.15677","volume":"179","author":"MK Klausen","year":"2022","unstructured":"Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A. The role of glucagon-like peptide 1 (GLP-1) in addictive disorders. Br J Pharmacol. 2022;179:625\u201341. https:\/\/doi.org\/10.1111\/bph.15677.","journal-title":"Br J Pharmacol"},{"key":"3259_CR205","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1063033","volume":"14","author":"E Jerlhag","year":"2023","unstructured":"Jerlhag E. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies. Front Pharmacol. 2023;14:1063033. https:\/\/doi.org\/10.3389\/fphar.2023.1063033.","journal-title":"Front Pharmacol"},{"key":"3259_CR206","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00213-024-06637-2","volume":"242","author":"A Fink-Jensen","year":"2025","unstructured":"Fink-Jensen A, W\u00f6rtwein G, Klausen MK, Holst JJ, Hartmann B, Thomsen M, et al. Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys. Psychopharmacology (Berl). 2025;242:63\u201370. https:\/\/doi.org\/10.1007\/s00213-024-06637-2.","journal-title":"Psychopharmacology (Berl)"},{"key":"3259_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2020.113279","volume":"229","author":"JE Douton","year":"2021","unstructured":"Douton JE, Norgren R, Grigson PS. Effects of a glucagon-like peptide-1 analog on appetitive and consummatory behavior for rewarding and aversive gustatory stimuli in rats. Physiol Behav. 2021;229:113279. https:\/\/doi.org\/10.1016\/j.physbeh.2020.113279.","journal-title":"Physiol Behav"},{"key":"3259_CR208","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41366-024-01500-y","volume":"49","author":"S Bettadapura","year":"2025","unstructured":"Bettadapura S, Dowling K, Jablon K, Al-Humadi AW, le Roux CW. Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities. Int J Obes. 2025;49:418\u201326. https:\/\/doi.org\/10.1038\/s41366-024-01500-y.","journal-title":"Int J Obes"},{"key":"3259_CR209","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuint.2013.10.003","volume":"73","author":"IA Reddy","year":"2014","unstructured":"Reddy IA, Stanwood GD, Galli A. Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward. Neurochem Int. 2014;73:49\u201355. https:\/\/doi.org\/10.1016\/j.neuint.2013.10.003.","journal-title":"Neurochem Int"},{"key":"3259_CR210","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fnins.2013.00181","volume":"7","author":"KP Skibicka","year":"2013","unstructured":"Skibicka KP. The central GLP-1: implications for food and drug reward. Front Neurosci. 2013;7:181. https:\/\/doi.org\/10.3389\/fnins.2013.00181.","journal-title":"Front Neurosci"},{"key":"3259_CR211","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2020.614884","volume":"14","author":"CY Eren-Yazicioglu","year":"2020","unstructured":"Eren-Yazicioglu CY, Yigit A, Dogruoz RE, Yapici-Eser H. Can GLP-1 Be a target for reward system related disorders? A qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol. Front Behav Neurosci. 2020;14:614884. https:\/\/doi.org\/10.3389\/fnbeh.2020.614884.","journal-title":"Front Behav Neurosci"},{"key":"3259_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2024.114622","volume":"283","author":"S Badulescu","year":"2024","unstructured":"Badulescu S, Tabassum A, Le GH, Wong S, Phan L, Gill H, et al. Glucagon-like peptide 1 agonist and effects on reward behaviour: a systematic review. Physiol Behav. 2024;283:114622. https:\/\/doi.org\/10.1016\/j.physbeh.2024.114622.","journal-title":"Physiol Behav"},{"key":"3259_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110303","volume":"110","author":"E Guerrero-Hreins","year":"2021","unstructured":"Guerrero-Hreins E, Goldstone AP, Brown RM, Sumithran P. The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: a review. Prog Neuropsychopharmacol Biol Psychiatry. 2021;110:110303. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110303.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3259_CR214","doi-asserted-by":"publisher","first-page":"1229086","DOI":"10.1080\/23312025.2016.1229086","volume":"2","author":"MK Holt","year":"2016","unstructured":"Holt MK, Trapp S. The physiological role of the brain GLP-1 system in stress. Cogent Biol. 2016;2:1229086. https:\/\/doi.org\/10.1080\/23312025.2016.1229086.","journal-title":"Cogent Biol"},{"key":"3259_CR215","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.physbeh.2013.04.003","volume":"122","author":"S Ghosal","year":"2013","unstructured":"Ghosal S, Myers B, Herman JP. Role of central glucagon-like peptide-1 in stress regulation. Physiol Behav. 2013;122:201\u20137. https:\/\/doi.org\/10.1016\/j.physbeh.2013.04.003.","journal-title":"Physiol Behav"},{"key":"3259_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118645","volume":"264","author":"H Yaribeygi","year":"2021","unstructured":"Yaribeygi H, Rashidy-Pour A, Atkin SL, Jamialahmadi T, Sahebkar A. GLP-1 mimetics and cognition. Life Sci. 2021;264:118645. https:\/\/doi.org\/10.1016\/j.lfs.2020.118645.","journal-title":"Life Sci"},{"key":"3259_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.970925","volume":"16","author":"N Reich","year":"2022","unstructured":"Reich N, H\u00f6lscher C. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer\u2019s and Parkinson\u2019s disease: an in-depth review. Front Neurosci. 2022;16:970925. https:\/\/doi.org\/10.3389\/fnins.2022.970925.","journal-title":"Front Neurosci"},{"key":"3259_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102343","volume":"98","author":"KO Kopp","year":"2024","unstructured":"Kopp KO, Glotfelty EJ, Li Y, Lahiri DK, Greig NH. Type 2 diabetes mellitus\/obesity drugs: a neurodegenerative disorders savior or a bridge too far? Ageing Res Rev. 2024;98:102343. https:\/\/doi.org\/10.1016\/j.arr.2024.102343.","journal-title":"Ageing Res Rev"},{"key":"3259_CR219","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01821-3","volume":"25","author":"W Halloum","year":"2024","unstructured":"Halloum W, Dughem YA, Beier D, Pellesi L. Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review. J Headache Pain. 2024;25:112. https:\/\/doi.org\/10.1186\/s10194-024-01821-3.","journal-title":"J Headache Pain"},{"key":"3259_CR220","doi-asserted-by":"publisher","first-page":"R726","DOI":"10.1152\/ajpregu.1997.272.2.R726","volume":"272","author":"TE Thiele","year":"1997","unstructured":"Thiele TE, Van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol Regul Integr Comp Physiol. 1997;272:R726\u2013R730.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3259_CR221","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.4103\/1673-5374.389626","volume":"19","author":"Y Diz-Chaves","year":"2024","unstructured":"Diz-Chaves Y, Maastor Z, Spuch C, Lamas JA, Gonz\u00e1lez-Mat\u00edas LC, Mallo F. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain. Neural Regen Res. 2024;19:1671\u20137. https:\/\/doi.org\/10.4103\/1673-5374.389626.","journal-title":"Neural Regen Res"},{"key":"3259_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp KO, Glotfelty EJ, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment. Pharmacol Res. 2022;186:106550. https:\/\/doi.org\/10.1016\/j.phrs.2022.106550.","journal-title":"Pharmacol Res"},{"key":"3259_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104615","volume":"152","author":"G Yoon","year":"2020","unstructured":"Yoon G, Kim Y-K, Song J. Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure. Pharmacol Res. 2020;152:104615. https:\/\/doi.org\/10.1016\/j.phrs.2019.104615.","journal-title":"Pharmacol Res"},{"key":"3259_CR224","doi-asserted-by":"publisher","unstructured":"Klausen MK, Jensen ME, M\u00f8ller M, Le Dous N, Jensen A\u00d8, Zeeman VA, et al. Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial. JCI Insight. 2022;7. https:\/\/doi.org\/10.1172\/jci.insight.159863.","DOI":"10.1172\/jci.insight.159863"},{"key":"3259_CR225","doi-asserted-by":"publisher","unstructured":"Probst L, Monnerat S, Vogt DR, Lengsfeld S, Burkard T, Meienberg A, et al. Effects of dulaglutide on alcohol consumption during smoking cessation. JCI Insight. 2023;8. https:\/\/doi.org\/10.1172\/jci.insight.170419.","DOI":"10.1172\/jci.insight.170419"},{"key":"3259_CR226","doi-asserted-by":"publisher","unstructured":"Richards JR, Dorand MF, Royal K, Mnajjed L, Paszkowiak M, Simmons WK Significant decrease in alcohol use disorder symptoms secondary to semaglutide therapy for weight loss: a case series. J Clin Psychiatry. 2023;85. https:\/\/doi.org\/10.4088\/JCP.23m15068.","DOI":"10.4088\/JCP.23m15068"},{"key":"3259_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48267-2","volume":"13","author":"F Quddos","year":"2023","unstructured":"Quddos F, Hubshman Z, Tegge A, Sane D, Marti E, Kablinger AS, et al. Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity. Sci Rep. 2023;13:20998. https:\/\/doi.org\/10.1038\/s41598-023-48267-2.","journal-title":"Sci Rep"},{"key":"3259_CR228","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15288\/jsad.23-00318","volume":"85","author":"MP Bremmer","year":"2024","unstructured":"Bremmer MP, Hendershot CS. Social media as pharmacovigilance: the potential for patient reports to inform clinical research on glucagon-like peptide 1 (GLP-1) receptor agonists for substance use disorders. J Stud Alcohol Drugs. 2024;85:5\u201311. https:\/\/doi.org\/10.15288\/jsad.23-00318.","journal-title":"J Stud Alcohol Drugs"},{"key":"3259_CR229","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/brainsci14060617","volume":"14","author":"D Arillotta","year":"2024","unstructured":"Arillotta D, Floresta G, Papanti Pelletier GD, Guirguis A, Corkery JM, Martinotti G, et al. Exploring the potential impact of GLP-1 receptor agonists on substance use, compulsive behavior, and libido: insights from social media using a mixed-methods approach. Brain Sci. 2024;14:617.","journal-title":"Brain Sci"},{"key":"3259_CR230","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48780-6","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nat Commun. 2024;15:4548. https:\/\/doi.org\/10.1038\/s41467-024-48780-6.","journal-title":"Nat Commun"},{"key":"3259_CR231","doi-asserted-by":"publisher","unstructured":"Farokhnia M, Tazare J, Pince CL, Bruns N 6th, Gray JC, Lo Re V 3rd, et al. Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake. J Clin Invest. 2025;135. https:\/\/doi.org\/10.1172\/jci188314.","DOI":"10.1172\/jci188314"},{"key":"3259_CR232","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bcpt.13776","volume":"131","author":"IK Wium-Andersen","year":"2022","unstructured":"Wium-Andersen IK, Wium-Andersen MK, Fink-Jensen A, Rungby J, J\u00f8rgensen MB, Osler M. Use of GLP-1 receptor agonists and subsequent risk of alcohol-related events. A nationwide register-based cohort and self-controlled case series study. Basic Clin Pharmacol Toxicol. 2022;131:372\u20139. https:\/\/doi.org\/10.1111\/bcpt.13776.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3259_CR233","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/add.16679","volume":"120","author":"F Qeadan","year":"2025","unstructured":"Qeadan F, McCunn A, Tingey B. The association between glucose-dependent insulinotropic polypeptide and\/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: a real-world data analysis. Addiction. 2025;120:236\u201350. https:\/\/doi.org\/10.1111\/add.16679.","journal-title":"Addiction"},{"key":"3259_CR234","doi-asserted-by":"publisher","unstructured":"L\u00e4hteenvuo M, Tiihonen J, Solismaa A, Tanskanen A, Mittendorfer-Rutz E, Taipale H Repurposing semaglutide and liraglutide for alcohol use disorder. JAMA Psychiatry. 2024. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.3599.","DOI":"10.1001\/jamapsychiatry.2024.3599"},{"key":"3259_CR235","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41591-023-02634-8","volume":"29","author":"L Leggio","year":"2023","unstructured":"Leggio L, Hendershot CS, Farokhnia M, Fink-Jensen A, Klausen MK, Schacht JP, et al. GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders. Nat Med. 2023;29:2993\u20135. https:\/\/doi.org\/10.1038\/s41591-023-02634-8.","journal-title":"Nat Med"},{"key":"3259_CR236","doi-asserted-by":"publisher","unstructured":"Volkow ND, Xu R GLP-1R agonist medications for addiction treatment. Addiction. 2024. https:\/\/doi.org\/10.1111\/add.16626.","DOI":"10.1111\/add.16626"},{"key":"3259_CR237","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","volume":"82","author":"CS Hendershot","year":"2025","unstructured":"Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, et al. Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2025;82:395\u2013405. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.4789.","journal-title":"JAMA Psychiatry"},{"key":"3259_CR238","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.physbeh.2019.02.008","volume":"204","author":"M Farokhnia","year":"2019","unstructured":"Farokhnia M, Faulkner ML, Piacentino D, Lee MR, Leggio L. Ghrelin: from a gut hormone to a potential therapeutic target for alcohol use disorder. Physiol Behav. 2019;204:49\u201357. https:\/\/doi.org\/10.1016\/j.physbeh.2019.02.008.","journal-title":"Physiol Behav"},{"key":"3259_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109643","volume":"238","author":"RS Richardson","year":"2023","unstructured":"Richardson RS, Sulima A, Rice KC, Kucharczk JA, Janda KD, Nisbett KE, et al. Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice. Neuropharmacology. 2023;238:109643. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109643.","journal-title":"Neuropharmacology"},{"key":"3259_CR240","doi-asserted-by":"publisher","unstructured":"Faulkner ML, Farokhnia M, Lee MR, Farinelli L, Browning BD, Abshire K, et al. A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder. JCI Insight. 2024;9. https:\/\/doi.org\/10.1172\/jci.insight.182331.","DOI":"10.1172\/jci.insight.182331"},{"key":"3259_CR241","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2174\/1381612033454748","volume":"9","author":"TL Horvath","year":"2003","unstructured":"Horvath TL, Casta\u00f1eda T, Tang-Christensen M, Pagotto U, Tsch\u00f6p MH. Ghrelin as a potential anti-obesity target. Curr Pharm Des. 2003;9:1383\u201395. https:\/\/doi.org\/10.2174\/1381612033454748.","journal-title":"Curr Pharm Des"},{"key":"3259_CR242","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/psc.1177","volume":"15","author":"C Chollet","year":"2009","unstructured":"Chollet C, Meyer K, Beck-Sickinger AG. Ghrelin-a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues. J Pept Sci. 2009;15:711\u201330. https:\/\/doi.org\/10.1002\/psc.1177.","journal-title":"J Pept Sci"},{"key":"3259_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101128","volume":"46","author":"D Gupta","year":"2021","unstructured":"Gupta D, Ogden SB, Shankar K, Varshney S, Zigman JM. A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes. Mol Metab. 2021;46:101128. https:\/\/doi.org\/10.1016\/j.molmet.2020.101128.","journal-title":"Mol Metab"},{"key":"3259_CR244","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/7854_2016_55","volume":"33","author":"LC Walker","year":"2017","unstructured":"Walker LC, Lawrence AJ. The role of orexins\/hypocretins in alcohol use and abuse. Curr Top Behav Neurosci. 2017;33:221\u201346. https:\/\/doi.org\/10.1007\/7854_2016_55.","journal-title":"Curr Top Behav Neurosci"},{"key":"3259_CR245","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00213-018-4871-2","volume":"235","author":"DE Moorman","year":"2018","unstructured":"Moorman DE. The hypocretin\/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl). 2018;235:1663\u201380. https:\/\/doi.org\/10.1007\/s00213-018-4871-2.","journal-title":"Psychopharmacology (Berl)"},{"key":"3259_CR246","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.physbeh.2010.03.009","volume":"100","author":"AM Cason","year":"2010","unstructured":"Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin\/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav. 2010;100:419\u201328. https:\/\/doi.org\/10.1016\/j.physbeh.2010.03.009.","journal-title":"Physiol Behav"},{"key":"3259_CR247","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1749-6632.2012.06585.x","volume":"1264","author":"C Kotz","year":"2012","unstructured":"Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. Brain orexin promotes obesity resistance. Ann N Y Acad Sci. 2012;1264:72\u201386. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06585.x.","journal-title":"Ann N Y Acad Sci"},{"key":"3259_CR248","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ijo.2012.30","volume":"37","author":"CE Perez-Leighton","year":"2013","unstructured":"Perez-Leighton CE, Butterick-Peterson TA, Billington CJ, Kotz CM. Role of orexin receptors in obesity: from cellular to behavioral evidence. Int J Obes (Lond). 2013;37:167\u201374. https:\/\/doi.org\/10.1038\/ijo.2012.30.","journal-title":"Int J Obes (Lond)"},{"key":"3259_CR249","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/bph.17406","volume":"182","author":"C Aran\u00e4s","year":"2025","unstructured":"Aran\u00e4s C, Caffrey A, Edvardsson CE, Vestlund J, Schmidt HD, Jerlhag E. Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats. Br J Pharmacol. 2025;182:1292\u2013305. https:\/\/doi.org\/10.1111\/bph.17406.","journal-title":"Br J Pharmacol"},{"key":"3259_CR250","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1021\/acschemneuro.4c00133","volume":"15","author":"S Boukabara","year":"2024","unstructured":"Boukabara S, Farokhnia M, Leggio L. Amylin in alcohol addiction: a potential new treatment target or an adjuvant to other treatments? ACS Chem Neurosci. 2024;15:1609\u201310. https:\/\/doi.org\/10.1021\/acschemneuro.4c00133.","journal-title":"ACS Chem Neurosci"},{"key":"3259_CR251","doi-asserted-by":"publisher","unstructured":"Walker CS, Aitken JF, Vazhoor Amarsingh G, Zhang S, Cooper GJS Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus. Nat Rev Endocrinol. 2025. https:\/\/doi.org\/10.1038\/s41574-025-01125-9.","DOI":"10.1038\/s41574-025-01125-9"},{"key":"3259_CR252","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.molmet.2017.11.009","volume":"8","author":"CN Boyle","year":"2018","unstructured":"Boyle CN, Lutz TA, Le Foll C. Amylin - its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity. Mol Metab. 2018;8:203\u201310. https:\/\/doi.org\/10.1016\/j.molmet.2017.11.009.","journal-title":"Mol Metab"},{"key":"3259_CR253","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cmet.2021.12.024","volume":"34","author":"KH Flippo","year":"2022","unstructured":"Flippo KH, Trammell SAJ, Gillum MP, Aklan I, Perez MB, Yavuz Y, et al. FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit. Cell Metab. 2022;34:317\u2013328.e6. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.024.","journal-title":"Cell Metab"},{"key":"3259_CR254","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110389","volume":"27","author":"T Wang","year":"2024","unstructured":"Wang T, Tyler RE, Ilaka O, Cooper D, Farokhnia M, Leggio L. The crosstalk between fibroblast growth factor 21 (FGF21) system and substance use. iScience. 2024;27:110389. https:\/\/doi.org\/10.1016\/j.isci.2024.110389.","journal-title":"iScience"},{"key":"3259_CR255","doi-asserted-by":"publisher","unstructured":"Sonoda J, Chen MZ, Baruch A FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. Horm Mol Biol Clin Investig. 2017;30. https:\/\/doi.org\/10.1515\/hmbci-2017-0002.","DOI":"10.1515\/hmbci-2017-0002"},{"key":"3259_CR256","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/a-0623-2909","volume":"50","author":"N Babaknejad","year":"2018","unstructured":"Babaknejad N, Nayeri H, Hemmati R, Bahrami S, Esmaillzadeh A. An overview of FGF19 and FGF21: the therapeutic role in the treatment of the metabolic disorders and obesity. Horm Metab Res. 2018;50:441\u201352. https:\/\/doi.org\/10.1055\/a-0623-2909.","journal-title":"Horm Metab Res"},{"key":"3259_CR257","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.893833","volume":"13","author":"CB Padula","year":"2022","unstructured":"Padula CB, Tenekedjieva LT, McCalley DM, Al-Dasouqi H, Hanlon CA, Williams LM, et al. Targeting the salience network: a mini-review on a novel neuromodulation approach for treating alcohol use disorder. Front Psychiatry. 2022;13:893833. https:\/\/doi.org\/10.3389\/fpsyt.2022.893833.","journal-title":"Front Psychiatry"},{"key":"3259_CR258","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13309","volume":"22","author":"FV Gouveia","year":"2021","unstructured":"Gouveia FV, Silk E, Davidson B, Pople CB, Abrahao A, Hamilton J, et al. A systematic review on neuromodulation therapies for reducing body weight in patients with obesity. Obes Rev. 2021;22:e13309. https:\/\/doi.org\/10.1111\/obr.13309.","journal-title":"Obes Rev"},{"key":"3259_CR259","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","volume":"33","author":"D Eisenberg","year":"2023","unstructured":"Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33:3\u201314. https:\/\/doi.org\/10.1007\/s11695-022-06332-1","journal-title":"Obes Surg"},{"key":"3259_CR260","unstructured":"American Society for Metabolic and Bariatric Surgery. Estimate of Bariatric Surgery Numbers, 2011-2022. Accessed Septemer 3, 2024. https:\/\/asmbs.org\/resources\/estimate-of-bariatric-surgery-numbers\/."},{"key":"3259_CR261","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060640","volume":"151","author":"SE Hampl","year":"2023","unstructured":"Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151:e2022060640. https:\/\/doi.org\/10.1542\/peds.2022-060640.","journal-title":"Pediatrics"},{"key":"3259_CR262","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s11695-024-07118-3","volume":"34","author":"L Angrisani","year":"2024","unstructured":"Angrisani L, Santonicola A, Iovino P, Palma R, Kow L, Prager G, et al. IFSO Worldwide survey 2020\u20132021: current trends for bariatric and metabolic procedures. Obes Surg. 2024;34:1075\u201385. https:\/\/doi.org\/10.1007\/s11695-024-07118-3.","journal-title":"Obes Surg"},{"key":"3259_CR263","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/s2213-8587(13)70218-3","volume":"2","author":"S Madsbad","year":"2014","unstructured":"Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2:152\u201364. https:\/\/doi.org\/10.1016\/s2213-8587(13)70218-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3259_CR264","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1210\/en.2017-00564","volume":"158","author":"CR Hutch","year":"2017","unstructured":"Hutch CR, Sandoval D. The role of GLP-1 in the metabolic success of bariatric surgery. Endocrinology. 2017;158:4139\u201351. https:\/\/doi.org\/10.1210\/en.2017-00564.","journal-title":"Endocrinology"},{"key":"3259_CR265","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00000658-196909010-00003","volume":"170","author":"EE Mason","year":"1969","unstructured":"Mason EE, Ito C. Gastric bypass. Ann Surg. 1969;170:329\u201339. https:\/\/doi.org\/10.1097\/00000658-196909010-00003.","journal-title":"Ann Surg"},{"key":"3259_CR266","first-page":"1088","volume":"101","author":"L Navratil","year":"1959","unstructured":"Navratil L. Alcoholism and gastric resection. Munch Med Wochenschr. 1959;101:1088\u201390. Alkoholismus und Magenresektion","journal-title":"Munch Med Wochenschr"},{"key":"3259_CR267","first-page":"546","volume":"99","author":"L Navratil","year":"1957","unstructured":"Navratil L, Wenger R. [Gastrectomy and alcoholism]. Munch Med Wochenschr. 1957;99:546\u201350. Magenresektion und Trunksucht","journal-title":"Munch Med Wochenschr"},{"key":"3259_CR268","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.soard.2007.03.004","volume":"3","author":"S Sogg","year":"2007","unstructured":"Sogg S. Alcohol misuse after bariatric surgery: epiphenomenon or \u201cOprah\u201d phenomenon? Surg Obes Relat Dis. 2007;3:366\u20138. https:\/\/doi.org\/10.1016\/j.soard.2007.03.004.","journal-title":"Surg Obes Relat Dis"},{"key":"3259_CR269","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1007\/s11695-012-0749-2","volume":"22","author":"PK Thanos","year":"2012","unstructured":"Thanos PK, Subrize M, Delis F, Cooney RN, Culnan D, Sun M, et al. Gastric bypass increases ethanol and water consumption in diet-induced obese rats. Obes Surg. 2012;22:1884\u201392. https:\/\/doi.org\/10.1007\/s11695-012-0749-2.","journal-title":"Obes Surg"},{"key":"3259_CR270","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s11695-013-0884-4","volume":"23","author":"JF Davis","year":"2013","unstructured":"Davis JF, Tracy AL, Schurdak JD, Magrisso IJ, Grayson BE, Seeley RJ, et al. Roux en Y gastric bypass increases ethanol intake in the rat. Obes Surg. 2013;23:920\u201330. https:\/\/doi.org\/10.1007\/s11695-013-0884-4.","journal-title":"Obes Surg"},{"key":"3259_CR271","doi-asserted-by":"publisher","first-page":"e49121","DOI":"10.1371\/journal.pone.0049121","volume":"7","author":"A Hajnal","year":"2012","unstructured":"Hajnal A, Zharikov A, Polston JE, Fields MR, Tomasko J, Rogers AM, et al. Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism. PLoS ONE. 2012;7:e49121. https:\/\/doi.org\/10.1371\/journal.pone.0049121.","journal-title":"PLoS ONE"},{"key":"3259_CR272","doi-asserted-by":"publisher","first-page":"e83741","DOI":"10.1371\/journal.pone.0083741","volume":"8","author":"JE Polston","year":"2013","unstructured":"Polston JE, Pritchett CE, Tomasko JM, Rogers AM, Leggio L, Thanos PK, et al. Roux-en-Y gastric bypass increases intravenous ethanol self-administration in dietary obese rats. PLoS ONE. 2013;8:e83741. https:\/\/doi.org\/10.1371\/journal.pone.0083741.","journal-title":"PLoS ONE"},{"key":"3259_CR273","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.brainresbull.2017.08.004","volume":"138","author":"ER Orellana","year":"2018","unstructured":"Orellana ER, Jamis C, Horvath N, Hajnal A. Effect of vertical sleeve gastrectomy on alcohol consumption and preferences in dietary obese rats and mice: a plausible role for altered ghrelin signaling. Brain Res Bull. 2018;138:26\u201336. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.08.004.","journal-title":"Brain Res Bull"},{"key":"3259_CR274","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/oby.22415","volume":"27","author":"S Sirohi","year":"2019","unstructured":"Sirohi S, Skripnikova E, Davis JF. Vertical sleeve gastrectomy attenuates hedonic feeding without impacting alcohol drinking in rats. Obesity (Silver Spring). 2019;27:603\u201311. https:\/\/doi.org\/10.1002\/oby.22415.","journal-title":"Obesity (Silver Spring)"},{"key":"3259_CR275","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.brainresbull.2022.07.019","volume":"188","author":"E Orellana","year":"2022","unstructured":"Orellana E, Horvath N, Farokhnia M, Leggio L, Hajnal A. Changes in plasma ghrelin levels following surgical and non-surgical weight-loss in female rats predict alcohol use. Brain Res Bull. 2022;188:179\u201386. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.07.019.","journal-title":"Brain Res Bull"},{"key":"3259_CR276","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/adb.12436","volume":"22","author":"AN Blackburn","year":"2017","unstructured":"Blackburn AN, Hajnal A, Leggio L. The gut in the brain: the effects of bariatric surgery on alcohol consumption. Addict Biol. 2017;22:1540\u201353. https:\/\/doi.org\/10.1111\/adb.12436.","journal-title":"Addict Biol"},{"key":"3259_CR277","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.soard.2009.12.008","volume":"6","author":"KK Saules","year":"2010","unstructured":"Saules KK, Wiedemann A, Ivezaj V, Hopper JA, Foster-Hartsfield J, Schwarz D. Bariatric surgery history among substance abuse treatment patients: prevalence and associated features. Surg Obes Relat Dis. 2010;6:615\u201321. https:\/\/doi.org\/10.1016\/j.soard.2009.12.008.","journal-title":"Surg Obes Relat Dis"},{"key":"3259_CR278","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1001\/jama.2012.6147","volume":"307","author":"WC King","year":"2012","unstructured":"King WC, Chen JY, Mitchell JE, Kalarchian MA, Steffen KJ, Engel SG, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307:2516\u201325. https:\/\/doi.org\/10.1001\/jama.2012.6147.","journal-title":"JAMA"},{"key":"3259_CR279","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/2013.jamasurg.265","volume":"148","author":"A Conason","year":"2013","unstructured":"Conason A, Teixeira J, Hsu CH, Puma L, Knafo D, Geliebter A. Substance use following bariatric weight loss surgery. JAMA Surg. 2013;148:145\u201350. https:\/\/doi.org\/10.1001\/2013.jamasurg.265.","journal-title":"JAMA Surg"},{"key":"3259_CR280","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.soard.2017.03.021","volume":"13","author":"WC King","year":"2017","unstructured":"King WC, Chen JY, Courcoulas AP, Dakin GF, Engel SG, Flum DR, et al. Alcohol and other substance use after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis. 2017;13:1392\u2013402. https:\/\/doi.org\/10.1016\/j.soard.2017.03.021.","journal-title":"Surg Obes Relat Dis"},{"key":"3259_CR281","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamasurg.2013.700","volume":"148","author":"MP Ostlund","year":"2013","unstructured":"Ostlund MP, Backman O, Marsk R, Stockeld D, Lagergren J, Rasmussen F, et al. Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery. JAMA Surg. 2013;148:374\u20137. https:\/\/doi.org\/10.1001\/jamasurg.2013.700.","journal-title":"JAMA Surg"},{"key":"3259_CR282","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/oby.20397","volume":"21","author":"PA Svensson","year":"2013","unstructured":"Svensson PA, Anveden \u00c5, Romeo S, Peltonen M, Ahlin S, Burza MA, et al. Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study. Obesity (Silver Spring). 2013;21:2444\u201351. https:\/\/doi.org\/10.1002\/oby.20397.","journal-title":"Obesity (Silver Spring)"},{"key":"3259_CR283","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/ije\/dyaa147","volume":"49","author":"M Bramming","year":"2021","unstructured":"Bramming M, Becker U, J\u00f8rgensen MB, Neermark S, Bisgaard T, Tolstrup JS. Bariatric surgery and risk of alcohol use disorder: a Register-Based Cohort study. Int J Epidemiol. 2021;49:1826\u201335. https:\/\/doi.org\/10.1093\/ije\/dyaa147.","journal-title":"Int J Epidemiol"},{"key":"3259_CR284","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s00464-018-6545-x","volume":"33","author":"N Ibrahim","year":"2019","unstructured":"Ibrahim N, Alameddine M, Brennan J, Sessine M, Holliday C, Ghaferi AA. New onset alcohol use disorder following bariatric surgery. Surg Endosc. 2019;33:2521\u201330. https:\/\/doi.org\/10.1007\/s00464-018-6545-x.","journal-title":"Surg Endosc"},{"key":"3259_CR285","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11695-021-05847-3","volume":"32","author":"E Wong","year":"2022","unstructured":"Wong E, Fleishman A, Brem A, Jones DB, Wee CC. High-risk alcohol use and disordered eating behavior before and 1 year after sleeve gastrectomy. Obes Surg. 2022;32:593\u20138. https:\/\/doi.org\/10.1007\/s11695-021-05847-3.","journal-title":"Obes Surg"},{"key":"3259_CR286","doi-asserted-by":"publisher","first-page":"e2028117","DOI":"10.1001\/jamanetworkopen.2020.28117","volume":"3","author":"ML Maciejewski","year":"2020","unstructured":"Maciejewski ML, Smith VA, Berkowitz TSZ, Arterburn DE, Mitchell JE, Olsen MK, et al. Association of bariatric surgical procedures with changes in unhealthy alcohol use among US veterans. JAMA Netw Open. 2020;3:e2028117. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.28117.","journal-title":"JAMA Netw Open"},{"key":"3259_CR287","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s40519-018-0486-1","volume":"24","author":"I Coluzzi","year":"2019","unstructured":"Coluzzi I, Iossa A, Spinetti E, Silecchia G. Alcohol consumption after laparoscopic sleeve gastrectomy: 1-year results. Eat Weight Disord. 2019;24:1131\u20136. https:\/\/doi.org\/10.1007\/s40519-018-0486-1.","journal-title":"Eat Weight Disord"},{"key":"3259_CR288","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jamasurg.2022.6410","volume":"158","author":"N Mahmud","year":"2023","unstructured":"Mahmud N, Panchal S, Abu-Gazala S, Serper M, Lewis JD, Kaplan DE. Association between bariatric surgery and alcohol use-related hospitalization and all-cause mortality in a veterans affairs cohort. JAMA Surg. 2023;158:162\u201371. https:\/\/doi.org\/10.1001\/jamasurg.2022.6410.","journal-title":"JAMA Surg"},{"key":"3259_CR289","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.112529","volume":"267","author":"SN Speed","year":"2024","unstructured":"Speed SN, Sherman GT, Wang T, Pince CL, Sanfilippo JE, Montemitro C, et al. Bariatric surgery and alcohol and substance use: a case-control survey study. Drug Alcohol Depend. 2024;267:112529. https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.112529.","journal-title":"Drug Alcohol Depend"},{"key":"3259_CR290","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1365-2125.2002.01698.x","volume":"54","author":"H Klockhoff","year":"2002","unstructured":"Klockhoff H, N\u00e4slund I, Jones AW. Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery. Br J Clin Pharmacol. 2002;54:587\u201391. https:\/\/doi.org\/10.1046\/j.1365-2125.2002.01698.x.","journal-title":"Br J Clin Pharmacol"},{"key":"3259_CR291","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jamcollsurg.2010.09.020","volume":"212","author":"GA Woodard","year":"2011","unstructured":"Woodard GA, Downey J, Hernandez-Boussard T, Morton JM. Impaired alcohol metabolism after gastric bypass surgery: a case-crossover trial. J Am Coll Surg. 2011;212:209\u201314. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.09.020.","journal-title":"J Am Coll Surg"},{"key":"3259_CR292","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.soard.2013.02.002","volume":"9","author":"KJ Steffen","year":"2013","unstructured":"Steffen KJ, Engel SG, Pollert GA, Li C, Mitchell JE. Blood alcohol concentrations rise rapidly and dramatically after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9:470\u20133. https:\/\/doi.org\/10.1016\/j.soard.2013.02.002.","journal-title":"Surg Obes Relat Dis"},{"key":"3259_CR293","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1001\/jamasurg.2015.1884","volume":"150","author":"MY Pepino","year":"2015","unstructured":"Pepino MY, Okunade AL, Eagon JC, Bartholow BD, Bucholz K, Klein S. Effect of Roux-en-Y gastric bypass surgery: converting 2 alcoholic drinks to 4. JAMA Surg. 2015;150:1096\u20138. https:\/\/doi.org\/10.1001\/jamasurg.2015.1884.","journal-title":"JAMA Surg"},{"key":"3259_CR294","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.soard.2017.11.010","volume":"14","author":"MB Acevedo","year":"2018","unstructured":"Acevedo MB, Eagon JC, Bartholow BD, Klein S, Bucholz KK, Pepino MY. Sleeve gastrectomy surgery: when 2 alcoholic drinks are converted to 4. Surg Obes Relat Dis. 2018;14:277\u201383. https:\/\/doi.org\/10.1016\/j.soard.2017.11.010.","journal-title":"Surg Obes Relat Dis"},{"key":"3259_CR295","doi-asserted-by":"publisher","first-page":"e223711","DOI":"10.1001\/jamanetworkopen.2022.3711","volume":"5","author":"N Seyedsadjadi","year":"2022","unstructured":"Seyedsadjadi N, Acevedo MB, Alfaro R, Ramchandani VA, Plawecki MH, Rowitz B, et al. Site of alcohol first-pass metabolism among women. JAMA Netw Open. 2022;5:e223711 https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.3711.","journal-title":"JAMA Netw Open"},{"key":"3259_CR296","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.soard.2020.01.014","volume":"16","author":"MB Acevedo","year":"2020","unstructured":"Acevedo MB, Teran-Garcia M, Bucholz KK, Eagon JC, Bartholow BD, Burd NA, et al. Alcohol sensitivity in women after undergoing bariatric surgery: a Cross-Sectional study. Surg Obes Relat Dis. 2020;16:536\u201344. https:\/\/doi.org\/10.1016\/j.soard.2020.01.014.","journal-title":"Surg Obes Relat Dis"},{"key":"3259_CR297","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/bf02245161","volume":"107","author":"H de Wit","year":"1992","unstructured":"de Wit H, Bodker B, Ambre J. Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology (Berl). 1992;107:352\u20138. https:\/\/doi.org\/10.1007\/bf02245161.","journal-title":"Psychopharmacology (Berl)"},{"key":"3259_CR298","unstructured":"National Institute on Alcohol Abuse and Alcoholism. What colleges need to know now. An update on college drinking research. Bethesda, MD: NIAAA; 2024. Available from: https:\/\/www.collegedrinkingprevention.gov\/sites\/cdp\/files\/documents\/1College_Q7%20Bulletin-508_361C4E.pdf."},{"key":"3259_CR299","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1530-0277.2011.01459.x","volume":"35","author":"DN Linsenbardt","year":"2011","unstructured":"Linsenbardt DN, Moore EM, Griffin KD, Gigante ED, Boehm SL 2nd. Tolerance to ethanol\u2019s ataxic effects and alterations in ethanol-induced locomotion following repeated binge-like ethanol intake using the DID model. Alcohol Clin Exp Res. 2011;35:1246\u201355. https:\/\/doi.org\/10.1111\/j.1530-0277.2011.01459.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"3259_CR300","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173155","volume":"204","author":"SK Elvig","year":"2021","unstructured":"Elvig SK, McGinn MA, Smith C, Arends MA, Koob GF, Vendruscolo LF. Tolerance to alcohol: a critical yet understudied factor in alcohol addiction. Pharmacol Biochem Behav. 2021;204:173155. https:\/\/doi.org\/10.1016\/j.pbb.2021.173155.","journal-title":"Pharmacol Biochem Behav"},{"key":"3259_CR301","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jamcollsurg.2012.06.008","volume":"215","author":"EM Changchien","year":"2012","unstructured":"Changchien EM, Woodard GA, Hernandez-Boussard T, Morton JM. Normal alcohol metabolism after gastric banding and sleeve gastrectomy: a case-cross-over trial. J Am Coll Surg. 2012;215:475\u20139. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.06.008.","journal-title":"J Am Coll Surg"},{"key":"3259_CR302","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s00464-014-3790-5","volume":"29","author":"AS Gallo","year":"2015","unstructured":"Gallo AS, Berducci MA, Nijhawan S, Nino DF, Broderick RC, Harnsberger CR, et al. Alcohol metabolism is not affected by sleeve gastrectomy. Surg Endosc. 2015;29:1088\u201393. https:\/\/doi.org\/10.1007\/s00464-014-3790-5.","journal-title":"Surg Endosc"},{"key":"3259_CR303","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.neuropharm.2018.01.013","volume":"136","author":"E Jerlhag","year":"2018","unstructured":"Jerlhag E. GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence. Neuropharmacology. 2018;136:343\u20139. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.013.","journal-title":"Neuropharmacology"},{"key":"3259_CR304","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1073\/pnas.0812809106","volume":"106","author":"E Jerlhag","year":"2009","unstructured":"Jerlhag E, Egecioglu E, Landgren S, Salom\u00e9 N, Heilig M, Moechars D, et al. Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci USA. 2009;106:11318\u201323. https:\/\/doi.org\/10.1073\/pnas.0812809106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3259_CR305","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.biopsych.2014.03.019","volume":"76","author":"L Leggio","year":"2014","unstructured":"Leggio L, Zywiak WH, Fricchione SR, Edwards SM, de la Monte SM, Swift RM, et al. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation. Biol Psychiatry. 2014;76:734\u201341. https:\/\/doi.org\/10.1016\/j.biopsych.2014.03.019.","journal-title":"Biol Psychiatry"},{"key":"3259_CR306","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.biopsych.2012.01.035","volume":"72","author":"JF Davis","year":"2012","unstructured":"Davis JF, Schurdak JD, Magrisso IJ, Mul JD, Grayson BE, Pfluger PT, et al. Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats. Biol Psychiatry. 2012;72:354\u201360. https:\/\/doi.org\/10.1016\/j.biopsych.2012.01.035.","journal-title":"Biol Psychiatry"},{"key":"3259_CR307","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s11695-014-1317-8","volume":"24","author":"V Ivezaj","year":"2014","unstructured":"Ivezaj V, Saules KK, Schuh LM. New-onset substance use disorder after gastric bypass surgery: rates and associated characteristics. Obes Surg. 2014;24:1975\u201380. https:\/\/doi.org\/10.1007\/s11695-014-1317-8.","journal-title":"Obes Surg"},{"key":"3259_CR308","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.soard.2013.12.014","volume":"10","author":"CC Wee","year":"2014","unstructured":"Wee CC, Mukamal KJ, Huskey KW, Davis RB, Colten ME, Bolcic-Jankovic D, et al. High-risk alcohol use after weight loss surgery. Surg Obes Relat Dis. 2014;10:508\u201313. https:\/\/doi.org\/10.1016\/j.soard.2013.12.014.","journal-title":"Surg Obes Relat Dis"},{"key":"3259_CR309","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/oby.20803","volume":"22","author":"D Bradley","year":"2014","unstructured":"Bradley D, Magkos F, Eagon JC, Varela JE, Gastaldelli A, Okunade AL, et al. Matched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects. Obesity (Silver Spring). 2014;22:2026\u201331. https:\/\/doi.org\/10.1002\/oby.20803.","journal-title":"Obesity (Silver Spring)"},{"key":"3259_CR310","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1126\/science.36665","volume":"205","author":"ME Carroll","year":"1979","unstructured":"Carroll ME, France CP, Meisch RA. Food deprivation increases oral and intravenous drug intake in rats. Science. 1979;205:319\u201321. https:\/\/doi.org\/10.1126\/science.36665.","journal-title":"Science"},{"key":"3259_CR311","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s002130000674","volume":"154","author":"KD Carr","year":"2001","unstructured":"Carr KD, Kim GY, Cabeza de Vaca S. Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats. Psychopharmacology (Berl). 2001;154:420\u20138. https:\/\/doi.org\/10.1007\/s002130000674.","journal-title":"Psychopharmacology (Berl)"},{"key":"3259_CR312","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s00213-004-2037-x","volume":"179","author":"LJ Cheskin","year":"2005","unstructured":"Cheskin LJ, Hess JM, Henningfield J, Gorelick DA. Calorie restriction increases cigarette use in adult smokers. Psychopharmacology (Berl). 2005;179:430\u20136. https:\/\/doi.org\/10.1007\/s00213-004-2037-x.","journal-title":"Psychopharmacology (Berl)"},{"key":"3259_CR313","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1098\/rstb.2008.0107","volume":"363","author":"ND Volkow","year":"2008","unstructured":"Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci. 2008;363:3191\u2013200. https:\/\/doi.org\/10.1098\/rstb.2008.0107.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3259_CR314","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2019.104423","volume":"146","author":"K Nance","year":"2020","unstructured":"Nance K, Acevedo MB, Pepino MY. Changes in taste function and ingestive behavior following bariatric surgery. Appetite. 2020;146:104423 https:\/\/doi.org\/10.1016\/j.appet.2019.104423.","journal-title":"Appetite"},{"key":"3259_CR315","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1097\/sla.0000000000005759","volume":"278","author":"GE White","year":"2023","unstructured":"White GE, Boles RE, Courcoulas AP, Yanovski SZ, Zeller MH, Jenkins TM, et al. A prospective cohort of alcohol use and alcohol-related problems before and after metabolic and bariatric surgery in adolescents. Ann Surg. 2023;278:e519\u2013e525. https:\/\/doi.org\/10.1097\/sla.0000000000005759.","journal-title":"Ann Surg"},{"key":"3259_CR316","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/liv.14805","volume":"41","author":"JL Mellinger","year":"2021","unstructured":"Mellinger JL, Shedden K, Winder GS, Fernandez AC, Lee BP, Waljee J, et al. Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse. Liver Int. 2021;41:1012\u20139. https:\/\/doi.org\/10.1111\/liv.14805.","journal-title":"Liver Int"},{"key":"3259_CR317","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s11695-023-06490-w","volume":"33","author":"E Alvarado-Tapias","year":"2023","unstructured":"Alvarado-Tapias E, Marti-Aguado D, Kennedy K, Fern\u00e1ndez-Carrillo C, Ventura-Cots M, Morales-Arraez D, et al. Bariatric surgery is associated with alcohol-related liver disease and psychiatric disorders associated with AUD. Obes Surg. 2023;33:1494\u2013505. https:\/\/doi.org\/10.1007\/s11695-023-06490-w.","journal-title":"Obes Surg"},{"key":"3259_CR318","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","volume":"26","author":"F Rubino","year":"2020","unstructured":"Rubino F, Puhl RM, Cummings DE, Eckel RH, Ryan DH, Mechanick JI, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26:485\u201397. https:\/\/doi.org\/10.1038\/s41591-020-0803-x.","journal-title":"Nat Med"},{"key":"3259_CR319","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMp1917360","volume":"382","author":"ND Volkow","year":"2020","unstructured":"Volkow ND. Stigma and the toll of addiction. N Engl J Med. 2020;382:1289\u201390. https:\/\/doi.org\/10.1056\/NEJMp1917360.","journal-title":"N Engl J Med"},{"key":"3259_CR320","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.278.5335.45","volume":"278","author":"AI Leshner","year":"1997","unstructured":"Leshner AI. Addiction is a brain disease, and it matters. Science. 1997;278:45\u20137. https:\/\/doi.org\/10.1126\/science.278.5335.45.","journal-title":"Science"},{"key":"3259_CR321","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMra1511480","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374:363\u201371. https:\/\/doi.org\/10.1056\/NEJMra1511480.","journal-title":"N Engl J Med"},{"key":"3259_CR322","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41386-020-00950-y","volume":"46","author":"M Heilig","year":"2021","unstructured":"Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren L. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacol. 2021;46:1715\u201323. https:\/\/doi.org\/10.1038\/s41386-020-00950-y.","journal-title":"Neuropsychopharmacol"},{"key":"3259_CR323","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S2468-1253(21)00191-6","volume":"7","author":"AF DiMartini","year":"2022","unstructured":"DiMartini AF, Leggio L, Singal AK. Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models. Lancet Gastroenterol Hepatol. 2022;7:186\u201395. https:\/\/doi.org\/10.1016\/S2468-1253(21)00191-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3259_CR324","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.2023.19761","volume":"330","author":"M McPheeters","year":"2023","unstructured":"McPheeters M, O\u2019Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, et al. Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis. JAMA. 2023;330:1653\u201365. https:\/\/doi.org\/10.1001\/jama.2023.19761.","journal-title":"JAMA"},{"key":"3259_CR325","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/jamapsychiatry.2021.1271","volume":"78","author":"B Han","year":"2021","unstructured":"Han B, Jones CM, Einstein EB, Powell PA, Compton WM. Use of medications for alcohol use disorder in the US: results from the 2019 national survey on drug use and health. JAMA Psychiatry. 2021;78:922\u20134. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.1271.","journal-title":"JAMA Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03259-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:07:41Z","timestamp":1762884461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03259-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":325,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3259"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03259-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Leggio reports, outside his federal employment at the NIH, honoraria from the UK Medical Council on Alcohol (Editor-in-Chief for Alcohol and Alcoholism) and book royalties from Routledge (as editor of a textbook). Dr. Simmons serves on a clinical trial steering committee for Apollo Therapeutics,\u00a0and is a site PI for a clinical trial sponsored by Altimmune Inc. The other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}